Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2022 | May 02, 2022 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-39123 | |
Entity Registrant Name | SILVERGATE CAPITAL CORPORATION | |
Entity Incorporation, State or Country Code | MD | |
Entity Tax Identification Number | 33-0227337 | |
Entity Address, Address Line One | 4250 Executive Square | |
Entity Address, Address Line Two | Suite 300 | |
Entity Address, City or Town | La Jolla | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 92037 | |
City Area Code | 858 | |
Local Phone Number | 362-6300 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding (shares) | 31,633,815 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2022 | |
Entity Central Index Key | 0001312109 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Period Focus | Q1 | |
Class A Common Stock | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | Class A Common Stock, par value $0.01 per share | |
Trading Symbol | SI | |
Security Exchange Name | NYSE | |
Depositary Shares, Each Representing a 1/40th Interest in a Share of 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | Depositary Shares, Each Representing a 1/40th Interest in a Share of 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A | |
Trading Symbol | SI PRA | |
Security Exchange Name | NYSE |
CONSOLIDATED STATEMENTS OF FINA
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
ASSETS | ||
Cash and due from banks | $ 207,304 | $ 208,193 |
Interest earning deposits in other banks | 1,178,205 | 5,179,753 |
Cash and cash equivalents | 1,385,509 | 5,387,946 |
Securities available-for-sale, at fair value | 9,463,494 | 8,625,259 |
Securities held-to-maturity, at amortized cost (fair value of $2,578,976 at March 31, 2022) | 2,751,625 | 0 |
Loans held-for-sale, at lower of cost or fair value | 937,140 | 893,194 |
Loans held-for-investment, net of allowance for loan losses of $4,442 and $6,916 at March 31, 2022 and December 31, 2021, respectively | 739,014 | 887,304 |
Federal home loan and federal reserve bank stock, at cost | 61,719 | 34,010 |
Accrued interest receivable | 62,573 | 40,370 |
Premises and equipment, net | 1,678 | 3,008 |
Intangible assets | 189,977 | 0 |
Derivative assets | 46,415 | 34,056 |
Other assets | 158,869 | 100,348 |
Total assets | 15,798,013 | 16,005,495 |
Deposits: | ||
Noninterest bearing demand accounts | 13,323,535 | 14,213,472 |
Interest bearing accounts | 72,627 | 77,156 |
Total deposits | 13,396,162 | 14,290,628 |
Federal home loan bank advances | 800,000 | 0 |
Subordinated debentures, net | 15,848 | 15,845 |
Accrued expenses and other liabilities | 39,507 | 90,186 |
Total liabilities | 14,251,517 | 14,396,659 |
Commitments and contingencies | ||
Preferred stock, $0.01 par value—authorized 10,000 shares; $1,000 per share liquidation preference, 200 shares issued and outstanding at March 31, 2022 and December 31, 2021 | 2 | 2 |
Additional paid-in capital | 1,553,547 | 1,421,592 |
Retained earnings | 218,558 | 193,860 |
Accumulated other comprehensive loss | (225,927) | (6,922) |
Total shareholders’ equity | 1,546,496 | 1,608,836 |
Total liabilities and shareholders’ equity | 15,798,013 | 16,005,495 |
Class A common stock, $0.01 par value—authorized 125,000 shares; 31,630 and 30,403 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively | ||
Deposits: | ||
Common stock | 316 | 304 |
Class B non-voting common stock, $0.01 par value—authorized 25,000 shares; no shares issued and outstanding at March 31, 2022 and December 31, 2021 | ||
Deposits: | ||
Common stock | $ 0 | $ 0 |
CONSOLIDATED STATEMENTS OF FI_2
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION (Unaudited) (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Fair Value | $ 2,578,976 | |
Allowance for loan losses | $ 4,442 | $ 6,916 |
Preferred stock, par value (USD per share) | $ 0.01 | $ 0.01 |
Preferred stock authorized (shares) | 10,000,000 | 10,000,000 |
Preferred stock liquidation preference (USD per share) | $ 1,000 | $ 1,000 |
Preferred stock issued (shares) | 200,000 | 200,000 |
Preferred stock outstanding (shares) | 200,000 | 200,000 |
Class A common stock, $0.01 par value—authorized 125,000 shares; 31,630 and 30,403 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively | ||
Common stock, par value (USD per share) | $ 0.01 | $ 0.01 |
Common stock authorized (shares) | 125,000,000 | 125,000,000 |
Common stock issued (shares) | 31,630,000 | 30,403,000 |
Common stock outstanding (shares) | 31,630,000 | 30,403,000 |
Class B non-voting common stock, $0.01 par value—authorized 25,000 shares; no shares issued and outstanding at March 31, 2022 and December 31, 2021 | ||
Common stock, par value (USD per share) | $ 0.01 | $ 0.01 |
Common stock authorized (shares) | 25,000,000 | 25,000,000 |
Common stock issued (shares) | 0 | 0 |
Common stock outstanding (shares) | 0 | 0 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Interest income | ||
Loans, including fees | $ 18,287 | $ 16,597 |
Taxable securities | 17,779 | 3,592 |
Tax-exempt securities | 13,184 | 1,695 |
Other interest earning assets | 1,385 | 1,279 |
Dividends and other | 203 | 143 |
Total interest income | 50,838 | 23,306 |
Interest expense | ||
Deposits | 21 | 46 |
Federal home loan bank advances | 70 | 0 |
Subordinated debentures and other | 252 | 245 |
Total interest expense | 343 | 291 |
Net interest income before provision for loan losses | 50,495 | 23,015 |
Reversal of provision for loan losses | (2,474) | 0 |
Net interest income after provision for loan losses | 52,969 | 23,015 |
Noninterest income | ||
Deposit related fees | 8,968 | 7,124 |
Mortgage warehouse fee income | 651 | 954 |
Loss on sale of securities, net | (605) | 0 |
Other income | 436 | 12 |
Total noninterest income | 9,450 | 8,090 |
Noninterest expense | ||
Salaries and employee benefits | 15,544 | 10,990 |
Occupancy and equipment | 586 | 614 |
Communications and data processing | 2,762 | 1,621 |
Professional services | 2,954 | 1,717 |
Federal deposit insurance | 1,762 | 2,296 |
Correspondent bank charges | 828 | 497 |
Other loan expense | 384 | 174 |
Other general and administrative | 3,198 | 1,697 |
Total noninterest expense | 28,018 | 19,606 |
Income before income taxes | 34,401 | 11,499 |
Income tax expense (benefit) | 7,015 | (1,211) |
Net income | 27,386 | 12,710 |
Dividends on preferred stock | 2,688 | 0 |
Net income available to common shareholders. basic | 24,698 | 12,710 |
Net income available to common shareholders, diluted | $ 24,698 | $ 12,710 |
Basic earnings per common share (USD per share) | $ 0.79 | $ 0.56 |
Diluted earnings per common share (USD per share) | $ 0.79 | $ 0.55 |
Weighted average common shares outstanding: | ||
Basic (shares) | 31,219 | 22,504 |
Diluted (shares) | 31,401 | 23,010 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 27,386 | $ 12,710 |
Other comprehensive income (loss): | ||
Change in net unrealized loss on available-for-sale securities | (324,226) | (13,434) |
Less: Reclassification adjustment for net loss included in net income | 605 | 0 |
Less: Amortization of net unrealized losses on securities transferred from available-for-sale to held-to-maturity | 774 | 0 |
Income tax effect | 94,220 | 3,690 |
Unrealized loss on available-for-sale securities, net of tax | (228,627) | (9,744) |
Change in net unrealized gain (loss) on derivative assets | 14,603 | (7,460) |
Less: Reclassification adjustment for net gain included in net income | (951) | (504) |
Income tax effect | (4,030) | 2,189 |
Unrealized gain (loss) on derivative instruments, net of tax | 9,622 | (5,775) |
Other comprehensive loss | (219,005) | (15,519) |
Total comprehensive loss | $ (191,619) | $ (2,809) |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands | Total | Class A Common Stock | Class B Common Stock | Preferred Stock | Common StockClass A Common Stock | Common StockClass B Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Balance at beginning of period (shares) at Dec. 31, 2020 | 0 | 18,769,771 | 64,197 | ||||||
Balance at beginning of period at Dec. 31, 2020 | $ 294,299 | $ 0 | $ 188 | $ 1 | $ 129,726 | $ 118,348 | $ 46,036 | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Total comprehensive income (loss), net of tax | (2,809) | 12,710 | (15,519) | ||||||
Issuance of stock, net (shares) | 5,860,858 | ||||||||
Issuance of stock, net | 423,540 | $ 58 | 423,482 | ||||||
Conversion of Class B common stock to Class A common stock (shares) | 64,197 | (64,197) | |||||||
Conversion of Class B common stock to Class A common stock | 0 | $ 1 | $ (1) | ||||||
Stock-based compensation | 290 | 290 | |||||||
Exercise of stock options, net of shares withheld for employee taxes (shares) | 124,848 | ||||||||
Exercise of stock options, net of shares withheld for employee taxes | (1,699) | $ 1 | (1,700) | ||||||
Issuance of share-based awards, net of shares withheld for employee taxes (shares) | 294 | ||||||||
Balance at end of period (shares) at Mar. 31, 2021 | 0 | 24,819,968 | 0 | ||||||
Balance at end of period at Mar. 31, 2021 | 713,621 | $ 0 | $ 248 | $ 0 | 551,798 | 131,058 | 30,517 | ||
Balance at beginning of period (shares) at Dec. 31, 2021 | 30,403,000 | 0 | 200,000 | 30,402,706 | 0 | ||||
Balance at beginning of period at Dec. 31, 2021 | 1,608,836 | $ 2 | $ 304 | $ 0 | 1,421,592 | 193,860 | (6,922) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Total comprehensive income (loss), net of tax | (191,619) | 27,386 | (219,005) | ||||||
Dividends on preferred stock | (2,688) | (2,688) | |||||||
Issuance of stock, net (shares) | 1,221,217 | ||||||||
Issuance of stock, net | 131,517 | $ 12 | 131,505 | ||||||
Stock-based compensation | $ 729 | 729 | |||||||
Exercise of stock options, net of shares withheld for employee taxes (shares) | 1,840 | 1,840 | |||||||
Exercise of stock options, net of shares withheld for employee taxes | $ 30 | 30 | |||||||
Issuance of share-based awards, net of shares withheld for employee taxes (shares) | 4,552 | ||||||||
Issuance of share-based awards, net of shares withheld for employee taxes | (309) | (309) | |||||||
Balance at end of period (shares) at Mar. 31, 2022 | 31,630,000 | 0 | 200,000 | 31,630,315 | 0 | ||||
Balance at end of period at Mar. 31, 2022 | $ 1,546,496 | $ 2 | $ 316 | $ 0 | $ 1,553,547 | $ 218,558 | $ (225,927) |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Cash flows from operating activities | ||
Net income | $ 27,386,000 | $ 12,710,000 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 815,000 | 644,000 |
Amortization of securities premiums and discounts, net | 40,503,000 | 1,212,000 |
Amortization of loan premiums and discounts and deferred loan origination fees and costs, net | (253,000) | 250,000 |
Stock-based compensation | 729,000 | 290,000 |
Reversal of provision for loan losses | (2,474,000) | 0 |
Originations of loans held-for-sale | (2,972,952,000) | (3,384,431,000) |
Proceeds from sales of loans held-for-sale | 2,951,944,000 | 3,353,164,000 |
Other gains, net | (430,000) | (1,141,000) |
Other, net | 675,000 | 891,000 |
Changes in operating assets and liabilities: | ||
Accrued interest receivable and other assets | 15,480,000 | (4,119,000) |
Accrued expenses and other liabilities | (47,782,000) | 469,000 |
Net cash provided by (used in) operating activities | 13,641,000 | (20,061,000) |
Cash flows from investing activities | ||
Purchases of securities available-for-sale | (3,303,782,000) | (817,734,000) |
Proceeds from sale of securities available-for-sale | 432,059,000 | 0 |
Proceeds from paydowns and maturities of securities available-for-sale | 131,521,000 | 21,403,000 |
Purchases of securities held-to-maturity | (1,249,507,000) | 0 |
Proceeds from paydowns and maturities of securities held-to-maturity | 26,665,000 | 0 |
Loan originations/purchases and payments, net | (20,405,000) | 18,112,000 |
Proceeds from sale of loans, net | 149,070,000 | 0 |
Purchase of federal home loan and federal reserve bank stock, net | (27,708,000) | 0 |
Purchase of premises and equipment | (274,000) | (32,000) |
Payments to acquire intangible assets | (58,403,000) | 0 |
Proceeds from (payments for) derivative contracts, net | 2,176,000 | (8,439,000) |
Net cash used in investing activities | (3,918,588,000) | (786,690,000) |
Cash flows from financing activities | ||
Net change in noninterest bearing deposits | (889,937,000) | 1,755,702,000 |
Net change in interest bearing deposits | (4,529,000) | (1,357,000) |
Net change in federal home loan bank advances | 800,000,000 | 0 |
Proceeds from common stock issuance, net | (57,000) | 423,540,000 |
Payments of preferred stock dividends | (2,688,000) | 0 |
Proceeds from stock option exercise | 30,000 | 261,000 |
Taxes paid related to net share settlement of equity awards | (309,000) | (1,960,000) |
Net cash (used in) provided by financing activities | (97,490,000) | 2,176,186,000 |
Net (decrease) increase in cash and cash equivalents | (4,002,437,000) | 1,369,435,000 |
Cash and cash equivalents, beginning of period | 5,387,946,000 | 2,962,087,000 |
Cash and cash equivalents, end of period | 1,385,509,000 | 4,331,522,000 |
Supplemental cash flow information: | ||
Cash paid for interest | 454,000 | 444,000 |
Income taxes paid (refunded), net | 146,000 | (6,000) |
Supplemental noncash disclosures: | ||
Transfers of securities from available-for-sale to held-to-maturity | 1,534,713,000 | 0 |
Common stock issued in exchange for assets acquired | 131,574,000 | 0 |
Loans held-for-investment transferred to loans held-for-sale | $ 22,938,000 | $ 0 |
Nature of Business and Summary
Nature of Business and Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Nature of Business and Summary of Significant Accounting Policies | Nature of Business and Summary of Significant Accounting Policies Nature of Business The accompanying consolidated financial statements include the accounts of Silvergate Capital Corporation, a Maryland corporation, and its wholly-owned subsidiary, Silvergate Bank (the “Bank”), collectively referred to as (the “Company” or “Silvergate”). The Company’s assets consist primarily of its investment in the Bank and its primary activities are conducted through the Bank. The Company is a registered bank holding company that is subject to supervision by the Board of Governors of the Federal Reserve (“Federal Reserve”). The Bank is subject to regulation by the California Department of Financial Protection and Innovation, Division of Financial Institutions (“DFPI”), and, as a Federal Reserve member bank since 2012, the Federal Reserve Bank of San Francisco (“FRB”). The Bank’s deposits are insured up to legal limits by the Federal Deposit Insurance Corporation (“FDIC”). Financial Statement Preparation and Presentation The accompanying interim consolidated financial statements have been prepared by the Company, without an audit, in accordance with the instructions to the Quarterly Report on Form 10-Q, and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (the “SEC”) and, therefore, do not include all information and footnotes necessary for a fair presentation of its consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the unaudited financial information for the interim periods presented reflects all adjustments, consisting of only normal and recurring adjustments, necessary for a fair statement of the Company’s consolidated financial statements. These consolidated statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2021, included in the Company’s Annual Report on Form 10-K dated February 28, 2022. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. The consolidated financial statements include the accounts of the Company and all other entities in which it has a controlling financial interest. All significant intercompany accounts and transactions have been eliminated in consolidation. Unless the context requires otherwise, all references to the Company include its wholly owned subsidiaries. The accounting and reporting policies of the Company conform with GAAP and conform to predominant practices within the financial services industry. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates. Recently Issued Accounting Pronouncements Not Yet Effective In June 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (or “ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326) to replace the incurred loss model with an expected loss model, which is referred to as the current expected credit loss (or “CECL”) model. The CECL model is applicable to the measurement of credit losses on financial assets measured at amortized cost, including loan receivables, held to maturity debt securities, and reinsurance receivables. It also applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credit, financial guarantees, and other similar instruments) and net investments in leases recognized by a lessor. These amendments were initially effective for fiscal years beginning after December 15, 2019 for SEC registrants and after December 15, 2020, for Public Business Entities, or PBEs. In November 2019, the FASB issued ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates, which finalized the delay of the effective date for smaller reporting companies, as of the ASU 2019-10 effective date, such as the Company to apply the standards related to CECL, until fiscal years beginning after December 15, 2022. For debt securities with other than temporary impairment (OTTI), the guidance will be applied prospectively. The new methodology replaces the other-than-temporary impairment model and requires the recognition of an allowance for reductions in a security’s fair value attributable to declines in credit quality, instead of a direct write-down of the security when a valuation decline is determined to be other-than-temporary. Existing purchased credit impaired (PCI) assets will be grandfathered and classified as purchased credit deteriorated (PCD) assets at the date of adoption. The asset will be grossed up for the allowance for expected credit losses for all PCD assets at the date of adoption and will continue to recognize the noncredit discount in interest income based on the yield such assets as of the adoption date. Subsequent changes in expected credit losses will be recorded through the allowance. For all other assets with the scope of CECL, the cumulative effect adjustment will be recognized in retained earnings as of the beginning of the first reporting period in which the guidance is effective. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, which clarify that receivables arising from operating leases are not within the scope of Subtopic 326-20. Instead, impairment of receivables arising from operating leases should be accounted for in accordance with Topic 842, Leases. In March 2022, the FASB issued ASU 2022-02, Financial Instruments—Credit Losses (Topic 326), Troubled Debt Restructurings and Vintage Disclosures. The amendment eliminates the accounting guidance for troubled debt restructurings by creditors in Subtopic 310-40, while enhancing disclosure requirements for certain loan refinancings and restructuring by creditors when a borrow is experiencing financial difficulty. In addition, the update requires public business entities to disclose current-period gross write-offs for financing receivables and net investment in leases by year of origination. In relation to the loan portfolio, the Company formed a CECL implementation committee in 2018 which prepared a project plan to migrate towards the adoption date. As part of the project plan, the Company contracted a third-party vendor to assist in the application and analysis of ASU 2016-13 as well as a third party vendor to perform an independent model validation. As part of this process, the Company has determined preliminary loan pool segmentation under CECL, as well as evaluated the key economic loss drivers for each segment. The Company operationalized an initial CECL model during the second quarter of 2019 and is running this preliminary CECL model alongside the existing incurred loss methodology. The Company intends to continue to refine and run the model until the expected adoption date on January 1, 2023. The Company continues to evaluate the effects of ASU 2016-13 on its financial statements and disclosures. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (or “ASU 2020-04”), which provides temporary, optional guidance to ease the potential burden in accounting for, or recognizing the effects of, the transition away from the London Interbank Offered Rate (or “LIBOR”) or other interbank offered rate (reference rates) on financial reporting. On March 5, 2021, the U.K. Financial Conduct Authority, the regulatory supervisor for ICE Benchmark Administration, the administrator of LIBOR, announced that the overnight and one, three, six and twelve month USD LIBOR will be discontinued on June 30, 2023. It was originally expected that LIBOR would be discontinued by the end of 2021. To help with the transition to new reference rates, the ASU provides optional expedients and exceptions for applying GAAP to affected contract modifications and hedge accounting relationships. The guidance is applicable only to contracts or hedge accounting relationships that reference LIBOR or another reference rate expected to be discontinued. The expedients and exceptions in this update are available to all entities starting March 12, 2020 through December 31, 2022. In January 2020, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848), which clarifies the scope of Topic 848 to include derivative instruments impacted by discounting transition. The Company has created a subcommittee of the Asset Liability Management Committee to address the LIBOR transition and phase-out issues. The Company has identified its LIBOR-based contracts that will be impacted by the transition away from of LIBOR, and is incorporating fallback language in negotiated contracts and incorporating non-LIBOR reference rate and/or fallback language in new contracts to prepare for these changes. The Company is evaluating the impact that ASU 2020-04 will have on those financial assets where LIBOR is used as an index rate. In March 2022, the SEC released Staff Accounting Bulletin No. 121 (“SAB 121”), which provided interpretive guidance regarding accounting for obligations to safeguard crypto-assets an entity holds for platform users. The interpretive guidance requires an entity to recognize a liability on its balance sheet to reflect the obligation to safeguard the crypto-assets held for its platform users, along with a corresponding asset, both of which are measured at fair value. SAB 121 also requires disclosure of the nature and amount of crypto assets being safeguarded, how the fair value is determined, an entity’s accounting policy for safeguarding liabilities and corresponding assets and may require other information about risks and uncertainties arising from the entity’s safeguarding activities. SAB 121 is effective no later than the first interim or annual period ending after June 15, 2022, with retrospective application as of the beginning of the fiscal year. The Company is evaluating the impact that SAB 121 will have on its financial statements and disclosures. |
Securities
Securities | 3 Months Ended |
Mar. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Securities | Securities The following tables summarize the amortized cost, fair value of securities and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income and gross unrecognized gains and losses of available-for-sale and securities held-to-maturity at the dates indicated are as follows: March 31, 2022 Amortized Gross Gross Fair (Dollars in thousands) Available-for-sale securities U.S. Treasuries $ 34,889 $ — $ (165) $ 34,724 U.S. agency securities - excluding mortgage-backed securities 1,548,367 7,627 (7,333) 1,548,661 Residential mortgage-backed securities: Government agency mortgage-backed securities 1,781,961 62 (30,103) 1,751,920 Government agency collateralized mortgage obligation 1,385,198 1 (27,850) 1,357,349 Private-label collateralized mortgage obligation 1,342 12 (14) 1,340 Commercial mortgage-backed securities: Government agency mortgage-backed securities 1,338,333 2,360 (9,283) 1,331,410 Government agency collateralized mortgage obligation 70,839 — (60) 70,779 Private-label collateralized mortgage obligation 492,565 — (11,651) 480,914 Municipal bonds: Tax-exempt 2,900,600 65 (236,505) 2,664,160 Asset backed securities: Government sponsored student loan pools 226,738 — (4,501) 222,237 Total available-for-sale $ 9,780,832 $ 10,127 $ (327,465) $ 9,463,494 Amortized Gross Gross Fair (Dollars in thousands) Held-to-maturity securities U.S. Treasuries $ 1,245,293 $ — $ (42,488) $ 1,202,805 Residential mortgage-backed securities: Government agency mortgage-backed securities 547,423 — (34,896) 512,527 Government agency collateralized mortgage obligation 113,921 — (7,192) 106,729 Commercial mortgage-backed securities: Government agency collateralized mortgage obligation 53,408 — (5,179) 48,229 Municipal bonds: Tax-exempt 393,965 — (44,265) 349,700 Taxable 397,615 — (38,629) 358,986 Total held-to-maturity $ 2,751,625 $ — $ (172,649) $ 2,578,976 December 31, 2021 Amortized Gross Gross Fair (Dollars in thousands) Available-for-sale securities U.S. agency securities - excluding mortgage-backed securities $ 1,177,452 $ 7,320 $ (6,005) $ 1,178,767 Residential mortgage-backed securities: Government agency mortgage-backed securities 1,428,365 130 (14,378) 1,414,117 Government agency collateralized mortgage obligation 1,659,125 1,617 (15,739) 1,645,003 Private-label collateralized mortgage obligation 1,425 19 (11) 1,433 Commercial mortgage-backed securities: Government agency mortgage-backed securities 1,106,680 1,886 (4,962) 1,103,604 Government agency collateralized mortgage obligation 212,266 19 (1,370) 210,915 Private-label collateralized mortgage obligation 144,204 227 (797) 143,634 Municipal bonds: Tax-exempt 2,272,794 33,153 (8,210) 2,297,737 Taxable 403,279 341 (6,016) 397,604 Asset backed securities: Government sponsored student loan pools 233,374 97 (1,026) 232,445 Total available-for-sale $ 8,638,964 $ 44,809 $ (58,514) $ 8,625,259 During the three months ended March 31, 2022, the Company transferred, at fair value, $1.5 billion of residential mortgage-backed securities, commercial mortgage-backed securities, and municipal bonds from available-for-sale to held-to-maturity securities. The decision to re-designate the securities was based on the Company’s ability and intent to hold these securities to maturity. Factors used in assessing the ability to hold these securities to maturity were future liquidity needs and sources of funding. The related net unrealized after-tax loss of $14.1 million remained in accumulated other comprehensive income and will be amortized as a yield adjustment through earnings over the remaining life of the securities, offsetting the related net amortization of premium on the transferred securities. No gain or loss was recognized at the time of the transfer. Securities pledged for borrowings or for other purposes as required or permitted by law had a fair value of $1.2 billion as of March 31, 2022. There were no securities pledged as of December 31, 2021. At March 31, 2022, the total fair value of securities issued by one individual issuer, other than the U.S. Government and its agencies, in an amount greater than 10% of shareholders’ equity was $275.3 million. Securities with unrealized and unrecognized losses as of the dates indicated, aggregated by investment category and length of time that individual securities have been in a continuous unrealized or unrecognized loss position, are as follows: March 31, 2022 Less than 12 Months 12 Months or More Total Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized (Dollars in thousands) Available-for-sale securities U.S. Treasuries $ 34,724 $ (165) $ — $ — $ 34,724 $ (165) U.S. agency securities - excluding mortgage-backed securities 781,759 (7,101) 12,977 (232) 794,736 (7,333) Residential mortgage-backed securities: Government agency mortgage-backed securities 1,725,830 (30,102) 68 (1) 1,725,898 (30,103) Government agency collateralized mortgage obligation 1,155,505 (24,377) 199,890 (3,473) 1,355,395 (27,850) Private-label collateralized mortgage obligation 199 (3) 421 (11) 620 (14) Commercial mortgage-backed securities: Government agency mortgage-backed securities 871,284 (9,283) — — 871,284 (9,283) Government agency collateralized mortgage obligation 62,991 (60) — — 62,991 (60) Private-label collateralized mortgage obligation 474,175 (11,513) 6,739 (138) 480,914 (11,651) Municipal bonds: Tax-exempt 2,627,812 (236,505) — — 2,627,812 (236,505) Asset backed securities: Government sponsored student loan pools 186,833 (4,054) 35,405 (447) 222,238 (4,501) $ 7,921,112 $ (323,163) $ 255,500 $ (4,302) $ 8,176,612 $ (327,465) Less than 12 Months 12 Months or More Total Fair Value Unrecognized Fair Value Unrecognized Fair Value Unrecognized (Dollars in thousands) Held-to-maturity securities U.S. Treasuries $ 1,202,805 $ (42,488) $ — $ — $ 1,202,805 $ (42,488) Residential mortgage-backed securities: Government agency mortgage-backed securities 512,527 (40,537) — — 512,527 (40,537) Government agency collateralized mortgage obligation 106,646 (10,393) — — 106,646 (10,393) Commercial mortgage-backed securities: Government agency collateralized mortgage obligation 48,229 (6,241) — — 48,229 (6,241) Municipal bonds: Tax-exempt 349,700 (48,038) — — 349,700 (48,038) Taxable 358,986 (44,164) — — 358,986 (44,164) $ 2,578,893 $ (191,861) $ — $ — $ 2,578,893 $ (191,861) December 31, 2021 Less than 12 Months 12 Months or More Total Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized (Dollars in thousands) Available-for-sale securities U.S. agency securities - excluding mortgage-backed securities $ 761,711 $ (6,005) $ — $ — $ 761,711 $ (6,005) Residential mortgage-backed securities: Government agency mortgage-backed securities 1,357,080 (14,378) 70 — 1,357,150 (14,378) Government agency collateralized mortgage obligation 1,513,388 (15,732) 650 (7) 1,514,038 (15,739) Private-label collateralized mortgage obligation — — 433 (11) 433 (11) Commercial mortgage-backed securities: Government agency mortgage-backed securities 435,055 (4,962) — — 435,055 (4,962) Government agency collateralized mortgage obligation 189,397 (1,370) — — 189,397 (1,370) Private-label collateralized mortgage obligation 98,173 (656) 6,791 (141) 104,964 (797) Municipal bonds: Tax-exempt 1,025,689 (8,210) — — 1,025,689 (8,210) Taxable 339,041 (6,016) — — 339,041 (6,016) Asset backed securities: Government sponsored student loan pools 168,204 (803) 32,783 (223) 200,987 (1,026) $ 5,887,738 $ (58,132) $ 40,727 $ (382) $ 5,928,465 $ (58,514) As indicated in the tables above, as of March 31, 2022, the Company’s investment securities had gross unrealized losses totaling approximately $519.3 million, compared to approximately $58.5 million at December 31, 2021. The Company analyzes all of its securities with an unrealized loss position. For each security, the Company analyzed the credit quality and performed a projected cash flow analysis. In analyzing the credit quality, management may consider whether the securities are issued by the federal government, its agencies or its sponsored entities, or non-governmental entities, whether downgrades by bond rating agencies have occurred, and if credit quality has deteriorated. When performing a cash flow analysis, the Company uses models that project prepayments, default rates, and loss severities on the collateral supporting the security, based on underlying loan level borrower and loan characteristics and interest rate assumptions. Based on these analyses and reviews conducted by the Company, and assisted by independent third parties, the Company determined that none of its securities required an other-than-temporary impairment charge at March 31, 2022. Management continues to expect to recover the adjusted amortized cost basis of these securities. As of March 31, 2022, the Company had 622 securities whose estimated fair value declined 4.61% from the Company’s amortized cost; at December 31, 2021, the Company had 323 securities whose estimated fair value declined 0.98% from the Company’s amortized cost. These unrealized losses on securities are primarily due to changes in market interest rates or widening of credit spreads since their purchase dates. Current unrealized losses are expected to recover as the securities approach their respective maturity dates. Management believes it will more than likely not be required to sell before recovery of the amortized cost basis. For the three months ended March 31, 2022, the Company received $432.1 million in proceeds and recognized $3.8 million of gains and $4.4 million losses on sales of available-for-sale securities. There were no sales or calls of securities for the three months ended March 31, 2021. There were no credit losses associated with our securities portfolio recognized in earnings for the three months ended March 31, 2022 and 2021. The amortized cost and estimated fair value of investment securities as of the periods presented by contractual maturity are shown below. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. For purposes of the following table, the entire outstanding balance of residential and commercial mortgage-backed securities is categorized based on the final maturity date. March 31, December 31, Amortized Fair Amortized Fair (Dollars in thousands) Available-for-sale securities Within one year $ 34,889 $ 34,724 $ — $ — After one year through five years 1,611 1,531 2,243 2,170 After five years through ten years 1,503,068 1,502,618 1,406,395 1,401,733 After ten years 8,241,264 7,924,621 7,230,326 7,221,356 Total $ 9,780,832 $ 9,463,494 $ 8,638,964 $ 8,625,259 Held-to-maturity securities Within one year $ — $ — $ — $ — After one year through five years 1,245,293 1,202,805 — — After five years through ten years 275,375 249,523 — — After ten years 1,230,957 1,126,648 — — Total $ 2,751,625 $ 2,578,976 $ — $ — |
Loans
Loans | 3 Months Ended |
Mar. 31, 2022 | |
Receivables [Abstract] | |
Loans | Loans The following disclosure reports the Company’s loan portfolio segments and classes. Segments are groupings of similar loans at a level in which the Company has adopted systematic methods of documentation for determining its allowance for loan and credit losses. Classes are a disaggregation of the portfolio segments. The Company’s loan portfolio segments are: Real estate. Real estate loans include loans for which the Company holds one-to-four family, multi-family, commercial and construction real property as collateral. One-to-four family real estate loans primarily consist of non-qualified single-family residential mortgage loans and purchases of loan pools. Multi-family real estate loans have been offered for the purchase or refinancing of apartment properties located primarily in the Southern California market area. Commercial real estate lending activity has historically been primarily focused on investor properties that are owned by customers with a current banking relationship. The primary risks of real estate mortgage loans include the borrower’s inability to pay, material decreases in the value of the real estate that is being held as collateral and significant increases in interest rates, which may make the real estate mortgage loan unprofitable. Real estate loans also may be adversely affected by conditions in the real estate markets or in the general economy. Commercial and industrial . Commercial and industrial loans consist of U.S. dollar denominated loans to businesses that are collateralized almost exclusively by bitcoin or U.S. dollars, also known as our core lending product, SEN Leverage. Commercial and industrial loans may also consist of loans and lines of credit to businesses that are generally collateralized by accounts receivable, inventory, equipment, loan and lease receivables and other commercial assets, and may be supported by other credit enhancements such as personal guarantees. Risks may arise from differences between expected and actual cash flows and/or liquidity levels of the borrowers, as well as the type of collateral securing these loans and the reliability of the conversion thereof to cash. Borrowers accessing SEN Leverage provide bitcoin or U.S. dollars as collateral in an amount greater than the line of credit eligible to be advanced. The Bank works with regulated digital currency exchanges and other indirect lenders, as the case may be, to both act as its collateral custodian for such loans, and to liquidate the collateral in the event of a decline in collateral coverage below levels required in the borrower’s loan agreement. At no time does the Bank directly hold the pledged bitcoin digital currency. The Bank sets collateral coverage ratios at levels intended to yield collateral liquidation proceeds in excess of the borrower’s loan amount, but the borrower remains obligated for the payment of any deficiency notwithstanding any change in the condition of the exchange, financial or otherwise. The outstanding balance of gross SEN Leverage loans was $435.0 million and $335.9 million at March 31, 2022 and December 31, 2021, respectively. Unfunded commitments on SEN Leverage loans were $635.1 million and $234.6 million at March 31, 2022 and December 31, 2021, respectively. Reverse mortgage and other. From 2012 to 2014, the Company purchased home equity conversion mortgage (“HECM”) loans (also known as reverse mortgage loans) which are a special type of home loan, for homeowners aged 62 years or older, that requires no monthly mortgage payments and allows the borrower to receive payments from the lender. Reverse mortgage loan insurance is provided by the U.S. Federal Housing Administration through the HECM program which protects lenders from losses due to non-repayment of the loans when the outstanding loan balance exceeds collateral value at the time the loan is required to be repaid. Other loans consist of consumer loans and loans secured by personal property. Mortgage warehouse. The Company’s mortgage warehouse lending division provides short-term interim funding primarily for single-family residential mortgage loans originated by mortgage bankers or other lenders. The Company holds legal title to such loans from the date they are funded by the Company until the loans are sold to secondary market investors pursuant to pre-existing take out commitments, generally within a few weeks of origination, with loan sale proceeds applied to pay down Company funding. The Company’s mortgage warehouse loans may either be held-for-investment or held-for-sale depending on the underlying contract. At March 31, 2022 and December 31, 2021, gross mortgage warehouse loans were approximately $1.0 billion and $1.1 billion, respectively. A summary of loans as of the periods presented are as follows: March 31, December 31, (Dollars in thousands) Real estate loans: One-to-four family $ 94,161 $ 105,098 Multi-family 9,368 56,751 Commercial 80,279 210,136 Construction — 7,573 Commercial and industrial 434,960 335,862 Reverse mortgage and other 1,137 1,410 Mortgage warehouse 125,435 177,115 Total gross loans held-for-investment 745,340 893,945 Deferred fees, net (1,884) 275 Total loans held-for-investment 743,456 894,220 Allowance for loan losses (4,442) (6,916) Total loans held-for-investment, net $ 739,014 $ 887,304 Total loans held-for-sale (1) $ 937,140 $ 893,194 ________________________ (1) Loans held-for-sale includes $914.2 million and $893.2 million of mortgage warehouse loans as of March 31, 2022 and December 31, 2021, respectively. At March 31, 2022 and December 31, 2021, approximately $184.9 million and $381.0 million, respectively, of the Company’s gross loans held-for-investment were collateralized by various forms of real estate, primarily located in California. Real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy. At March 31, 2022 and December 31, 2021, approximately $435.0 million and $335.9 million, respectively, of the Company’s gross loans held-for-investment was collateralized primarily by bitcoin and U.S. dollars. The loan to value ratio of these loans fluctuates in relation to value of bitcoin held as collateral, which may be volatile and there is no assurance that customers will be able to timely provide additional collateral under these loans in a scenario where the value of the bitcoin drops precipitously. The Company monitors and manages concentrations of credit risk by making loans that are diversified by collateral type, placing limits on the amounts of various categories of loans relative to total Company capital, and conducting quarterly reviews of its portfolio by collateral type, geography, and other characteristics. Recorded investment in loans excludes accrued interest receivable due to immateriality. Accrued interest on loans held-for-investment totaled approximately $2.5 million and $3.3 million at March 31, 2022 and December 31, 2021, respectively. Allowance for Loan Losses The following tables present the allocation of the allowance for loan losses, as well as the activity in the allowance by loan class, and recorded investment in loans held-for-investment as of and for the periods presented: Three Months Ended March 31, 2022 One-to Multi- Commercial Construction Commercial Reverse Mortgage Total (Dollars in thousands) Balance, December 31, 2021 $ 1,023 $ 682 $ 2,017 $ 776 $ 1,566 $ 12 $ 840 $ 6,916 Charge-offs — — — — — — — — Recoveries — — — — — — — — Provision for loan losses (223) (582) (1,542) (776) 933 (1) (283) (2,474) Balance, March 31, 2022 $ 800 $ 100 $ 475 $ — $ 2,499 $ 11 $ 557 $ 4,442 Three Months Ended March 31, 2021 One-to Multi- Commercial Construction Commercial and Reverse Mortgage Total (Dollars in thousands) Balance, December 31, 2020 $ 1,245 $ 878 $ 1,810 $ 590 $ 1,931 $ 39 $ 423 $ 6,916 Charge-offs — — — — — — — — Recoveries — — — — — — — — Provision for loan losses 389 (50) 1,441 (97) (1,571) (21) (91) — Balance, March 31, 2021 $ 1,634 $ 828 $ 3,251 $ 493 $ 360 $ 18 $ 332 $ 6,916 March 31, 2022 One-to Multi- Commercial Construction Commercial Reverse Mortgage Total (Dollars in thousands) Amount of allowance attributed to: Specifically evaluated impaired loans $ 28 $ — $ — $ — $ — $ — $ — $ 28 General portfolio allocation 772 100 475 — 2,499 11 557 4,414 Total allowance for loan losses $ 800 $ 100 $ 475 $ — $ 2,499 $ 11 $ 557 $ 4,442 Loans evaluated for impairment: Specifically evaluated $ 4,126 $ — $ 1,236 $ — $ — $ 646 $ — $ 6,008 Collectively evaluated 90,575 9,367 79,037 — 432,533 501 125,435 737,448 Total loans held-for-investment $ 94,701 $ 9,367 $ 80,273 $ — $ 432,533 $ 1,147 $ 125,435 $ 743,456 December 31, 2021 One-to Multi- Commercial Construction Commercial Reverse Mortgage Total (Dollars in thousands) Amount of allowance attributed to: Specifically evaluated impaired loans $ 29 $ — $ — $ — $ — $ — $ — $ 29 General portfolio allocation 994 682 2,017 776 1,566 12 840 6,887 Total allowance for loan losses $ 1,023 $ 682 $ 2,017 $ 776 $ 1,566 $ 12 $ 840 $ 6,916 Loans evaluated for impairment: Specifically evaluated $ 4,229 $ — $ 1,956 $ — $ — $ 923 $ — $ 7,108 Collectively evaluated 101,609 56,855 208,170 7,502 335,362 499 177,115 887,112 Total loans held-for-investment $ 105,838 $ 56,855 $ 210,126 $ 7,502 $ 335,362 $ 1,422 $ 177,115 $ 894,220 Impaired Loans The following tables provide a summary of the Company’s investment in impaired loans as of and for the periods presented: March 31, 2022 Unpaid Recorded Related (Dollars in thousands) With no related allowance recorded: Real estate loans: One-to-four family $ 3,866 $ 3,827 $ — Commercial 1,237 1,236 — Reverse mortgage and other 646 646 — 5,749 5,709 — With an allowance recorded: Real estate loans: One-to-four family 296 299 28 296 299 28 Total impaired loans $ 6,045 $ 6,008 $ 28 December 31, 2021 Unpaid Recorded Related (Dollars in thousands) With no related allowance recorded: Real estate loans: One-to-four family $ 4,616 $ 3,927 $ — Commercial 1,955 1,956 — Reverse mortgage and other 914 923 — 7,485 6,806 — With an allowance recorded: Real estate loans: One-to-four family 323 302 29 323 302 29 Total impaired loans $ 7,808 $ 7,108 $ 29 Three Months Ended March 31, 2022 2021 Average Interest Average Interest (Dollars in thousands) With no related allowance recorded: Real estate loans: One-to-four family $ 3,856 $ 17 $ 4,979 $ 77 Commercial 2,526 20 9,795 128 Commercial and industrial — — 249 5 Reverse mortgage and other 829 — 616 — 7,211 37 15,639 210 With an allowance recorded: Real estate loans: One-to-four family 300 1 64 1 Reverse mortgage and other — — 258 — 300 1 322 1 Total impaired loans $ 7,511 $ 38 $ 15,961 $ 211 For purposes of this disclosure, the unpaid principal balance is not reduced for partial charge-offs. Cash basis interest income is not materially different than interest income recognized. Nonaccrual and Past Due Loans Nonperforming loans include individually evaluated impaired loans, loans for which the accrual of interest has been discontinued and loans 90 days or more past due and still accruing interest. The following tables present by loan class the aging analysis based on contractual terms, nonaccrual loans, and the Company’s recorded investment in loans held-for-investment as of the periods presented: March 31, 2022 30-59 60-89 Greater Total Current Total Nonaccruing Loans (Dollars in thousands) Real estate loans: One-to-four family $ 210 $ 189 $ 2,776 $ 3,175 $ 91,526 $ 94,701 $ 2,986 $ — Multi-family — — — — 9,367 9,367 — — Commercial — — — — 80,273 80,273 — — Construction — — — — — — — — Commercial and industrial — — — — 432,533 432,533 — — Reverse mortgage and other — — — — 1,147 1,147 646 — Mortgage warehouse — — — — 125,435 125,435 — — Total loans held-for-investment $ 210 $ 189 $ 2,776 $ 3,175 $ 740,281 $ 743,456 $ 3,632 $ — December 31, 2021 30-59 60-89 Greater Total Current Total Nonaccruing Loans (Dollars in thousands) Real estate loans: One-to-four family $ 1,176 $ — $ 2,985 $ 4,161 $ 101,677 $ 105,838 $ 3,080 $ — Multi-family — — — — 56,855 56,855 — — Commercial — — — — 210,126 210,126 — — Construction — — — — 7,502 7,502 — — Commercial and industrial — — — — 335,362 335,362 — — Reverse mortgage and other — — — — 1,422 1,422 923 — Mortgage warehouse — — — — 177,115 177,115 — — Total loans held-for-investment $ 1,176 $ — $ 2,985 $ 4,161 $ 890,059 $ 894,220 $ 4,003 $ — Troubled Debt Restructurings A loan is identified as a troubled debt restructuring (“TDR”) when a borrower is experiencing financial difficulties and, for economic or legal reasons related to these difficulties, the Company grants a concession to the borrower in the restructuring that it would not otherwise consider. In order to determine whether a borrower is experiencing financial difficulty, an evaluation is performed of the probability that the borrower will be in payment default on any of its debt in the foreseeable future without the modification. The Company has granted a concession when, as a result of the restructuring, it does not expect to collect all amounts due or within the time periods originally due under the original contract, including one or a combination of the following: a reduction of the stated interest rate of the loan; an extension of the maturity date at a stated rate of interest lower than the current market rate for new debt with similar risk; or a temporary forbearance with regard to the payment of principal or interest. All troubled debt restructurings are reviewed for potential impairment. Generally, a nonaccrual loan that is restructured remains on nonaccrual status for a minimum period of six months to demonstrate that the borrower can perform under the restructured terms. If the borrower’s performance under the new terms is not reasonably assured, the loan remains classified as a nonaccrual loan. Loans classified as TDRs are reported as impaired loans. As of March 31, 2022 and December 31, 2021, the Company had a recorded investment in TDRs of $1.7 million. The Company has allocated $28,000 of specific allowance for those loans at March 31, 2022 and $29,000 at December 31, 2021. The Company has not committed to advance additional amounts on these TDRs. No loans were modified as TDRs during the three months ended March 31, 2022 or 2021. A loan is considered to be in payment default once it is 30 days contractually past due under the modified terms. There were no loans modified as TDRs for which there was a payment default within twelve months during the three months ended March 31, 2022 or 2021. There was no provision for loan loss or charge-offs for TDR’s that subsequently defaulted during the three months ended March 31, 2022 or 2021. Credit Quality Indicators The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as: current financial information, historical payment experience, collateral adequacy, credit documentation, and current economic trends, among other factors. This analysis typically includes larger, nonhomogeneous loans such as commercial real estate and commercial and industrial loans. This analysis is performed on an ongoing basis as new information is obtained. The Company uses the following definitions for risk ratings: Pass : Loans in all classes that are not adversely rated, are contractually current as to principal and interest, and are otherwise in compliance with the contractual terms of the loan agreement. Management believes that there is a low likelihood of loss related to those loans that are considered pass. Special mention : Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the institution’s credit position at some future date. Substandard : Loans classified as substandard are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected. Doubtful : Loans classified as doubtful have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Loss : Credits rated as loss are charged-off. Management has no expectation of the recovery of any payments in respect of credits rated as loss. The following tables present by portfolio class the Company’s internal risk grading system as well as certain other information concerning the credit quality of the Company’s recorded investment in loans held-for-investment as of the periods presented. No assets were classified as loss or doubtful during the periods presented. Credit Risk Grades Pass Special Mention Substandard Doubtful Total (Dollars in thousands) March 31, 2022 Real estate loans: One-to-four family $ 91,166 $ 549 $ 2,986 $ — $ 94,701 Multi-family 9,367 — — — 9,367 Commercial 65,305 13,732 1,236 — 80,273 Construction — — — — — Commercial and industrial 432,533 — — — 432,533 Reverse mortgage and other 501 — 646 — 1,147 Mortgage warehouse 125,435 — — — 125,435 Total loans held-for-investment $ 724,307 $ 14,281 $ 4,868 $ — $ 743,456 Credit Risk Grades Pass Special Mention Substandard Doubtful Total (Dollars in thousands) December 31, 2021 Real estate loans: One-to-four family $ 102,307 $ 451 $ 3,080 $ — $ 105,838 Multi-family 56,855 — — — 56,855 Commercial 199,598 10,528 — — 210,126 Construction 7,502 — — — 7,502 Commercial and industrial 335,362 — — — 335,362 Reverse mortgage and other 499 — 923 — 1,422 Mortgage warehouse 177,115 — — — 177,115 Total loans held-for-investment $ 879,238 $ 10,979 $ 4,003 $ — $ 894,220 Purchases and Sales The following table presents loans held-for-investment purchased and/or sold during the year by portfolio segment: Three Months Ended March 31, 2022 2021 Purchases Sales (1) Purchases Sales (Dollars in thousands) Real estate loans: Multi-family $ — $ 54,227 $ — $ — Commercial — 155,011 — — Construction — 6,823 — — $ — $ 216,061 $ — $ — ________________________ (1) In conjunction with the loan sale during the three months ended March 31, 2022, the Company purchased a participating interest of $67.6 million of the loans sold to the buyer. Related Party Loans The Company had no outstanding balance of related party loans at March 31, 2022 and $7.7 million outstanding as of December 31, 2021. During the three months ended March 31, 2022, the Company received $7.7 million in proceeds from loan sales and principal payments. |
FHLB Advances and Other Borrowi
FHLB Advances and Other Borrowings | 3 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
FHLB Advances and Other Borrowings | FHLB Advances and Other Borrowings Federal Home Loan Bank (“FHLB”) Advances The following table sets forth certain information on our FHLB advances during the period presented: Three Months Ended Year Ended (Dollars in thousands) Amount outstanding at period-end $ 800,000 $ — Weighted average interest rate at period-end 0.43 % — FHLB advances or borrowing capacity can be secured with eligible collateral consisting of qualifying real estate loans or certain securities. Advances from the FHLB are subject to the FHLB’s collateral and underwriting requirements and as of March 31, 2022 and December 31, 2021, were limited in the aggregate to 35% of the Bank’s total assets. Loans and securities of approximately $2.4 billion and $1.4 billion were pledged to the FHLB as of March 31, 2022 and December 31, 2021, respectively. Unused borrowing capacity based on the lesser of the percentage of total assets and pledged collateral was approximately $1.2 billion and $1.0 billion as of March 31, 2022 and December 31, 2021, respectively. FRB Advances The Bank is also approved to borrow through the Discount Window of the Federal Reserve Bank of San Francisco on a collateralized basis without any fixed dollar limit. Loans with a carrying value of approximately $5.2 million and $6.0 million were pledged to the FRB at March 31, 2022 and December 31, 2021, respectively. The Bank’s borrowing capacity under the Federal Reserve’s discount window program was approximately $2.9 million and $5.2 million as of March 31, 2022 and December 31, 2021, respectively. At March 31, 2022 and December 31, 2021, there were no FRB advances outstanding. Federal Funds Purchased The Bank may borrow up to an aggregate $108.0 million, overnight on an unsecured basis, from two of its correspondent banks. Access to these funds is subject to liquidity availability, market conditions and any negative material change in the Bank’s credit profile. As of March 31, 2022 and December 31, 2021, the Company had no outstanding balance of federal funds purchased. |
Intangible Assets
Intangible Assets | 3 Months Ended |
Mar. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | Intangible Assets On January 31, 2022 the Company entered into an Asset Purchase Agreement (the “Purchase Agreement”) under which it acquired from the Libra Association, Diem Networks US HoldCo, Inc., Diem Networks US, Inc., Diem Networks II LLC, Diem LLC, and Diem Networks LLC, (collectively, the “Sellers”) certain intellectual property and other technology assets related to running a blockchain-based payment network. The assets acquired by the Company included development, deployment and operations infrastructure and tools for running a blockchain-based payment network designed to facilitate payments for commerce and cross-border remittances as well as proprietary software elements that are critical to running a regulatory-compliant stablecoin network. The technology is currently in a pre-launch phase, and no related amortization expense has been recorded for the acquired asset. The amortization period will begin when the developed technology is available for intended use. Under the terms of the Purchase Agreement, the aggregate purchase price for the acquired assets consisted of (i) $50.0 million in cash consideration and (ii) 1,221,217 shares of the Company’s Class A common stock. The value of the total transaction consideration was $181.6 million. The Company accounted for the purchase as an asset acquisition and capitalized direct transaction costs related to the purchase of $8.4 million, bringing the total intangible asset to $190.0 million at March 31, 2022. |
Subordinated Debentures, Net
Subordinated Debentures, Net | 3 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Subordinated Debentures, Net | Subordinated Debentures, NetA trust formed by the Company issued $12.5 million of floating rate trust preferred securities in July 2001 as part of a pooled offering of such securities. The Company issued subordinated debentures to the trust in exchange for its proceeds from the offering. The debentures and related accrued interest represent substantially all of the assets of the trust. The subordinated debentures bear interest at six-month LIBOR plus 375 basis points, which adjusts every six months in January and July of each year. Interest is payable semiannually. At March 31, 2022, the interest rate for the Company’s next scheduled payment was 4.19%, based on six-month LIBOR of 0.44%. On any January 25 or July 25 the Company may redeem the 2001 subordinated debentures at 100% of principal amount plus accrued interest. The 2001 subordinated debentures mature on July 25, 2031. A second trust formed by the Company issued $3.0 million of trust preferred securities in January 2005 as part of a pooled offering of such securities. The Company issued subordinated debentures to the trust in exchange for its proceeds from the offering. The debentures and related accrued interest represent substantially all of the assets of the trust. The subordinated debentures bear interest at three-month LIBOR plus 185 basis points, which adjusts every three months. Interest is payable quarterly. At March 31, 2022, the interest rate for the Company’s next scheduled payment was 2.68%, based on three-month LIBOR of 0.83%. On the 15th day of any March, June, September, or December, the Company may redeem the 2005 subordinated debentures at 100% of principal amount plus accrued interest. The 2005 subordinated debentures mature on March 15, 2035. The Company also retained a 3% minority interest in each of these trusts which is included in subordinated debentures. The balance of the equity in the trusts is comprised of mandatorily redeemable preferred securities. The subordinated debentures may be included in Tier I capital (with certain limitations applicable) under current regulatory guidelines and interpretations. The Company has the right to defer interest payments on the subordinated debentures from time to time for a period not to exceed five years. The outstanding balance of the subordinated debentures was $15.8 million, net of $0.1 million unamortized debt issuance costs as of March 31, 2022 and December 31, 2021. |
Derivative and Hedging Activiti
Derivative and Hedging Activities | 3 Months Ended |
Mar. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative and Hedging Activities | Derivative and Hedging Activities The Company is exposed to certain risks relating to its ongoing business operations. The Company utilizes interest rate derivatives as part of its asset liability management strategy to help manage its interest rate risk position. The notional amount of the derivative does not represent amounts exchanged by the parties. The amount exchanged is determined by reference to the notional amount and the other terms of the individual derivative agreements. In accordance with accounting guidance, changes in the fair value of derivatives designated and that qualify as cash flow hedges are initially recorded in accumulated other comprehensive income (“AOCI”), reclassified into earnings in the same period or periods during which the hedged transaction affects earnings and is presented in the same income statement line item as the earnings effect of the hedged item. The Company assesses the effectiveness of each hedging relationship by comparing the changes in cash flows of the derivative hedging instrument with the changes in cash flows of the designated hedged transactions. For cash flow and fair value hedges, the initial fair value of hedge components excluded from the assessment of effectiveness is recognized in earnings under a systematic and rational method over the life of the hedging instrument and is presented in the same income statement line item as the earnings effect of the hedged item. Any difference between the change in the fair value of the hedge components excluded from the assessment of effectiveness and the amounts recognized in earnings is recorded as a component of other comprehensive income. For a fair value hedge, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item, are recognized in current earnings as fair values change. The change in fair value of the hedged item is recorded as a basis adjustment to the hedged assets or liabilities. The amount included as a basis adjustment would be reclassified to current earnings on a straight-line basis over the original life of the hedged item should the hedges no longer be considered effective. Interest rate swaps. In 2020, the Company entered into two pay-fixed/receive floating rate interest rate swaps (the “Swap Agreements”) for a notional amount of $14.3 million that were designated as fair value hedges of certain available-for-sale securities. The Swap Agreements were determined to be fully effective during the periods presented and therefore no amount of ineffectiveness has been included in net income. In October 2021, the Company sold the swaps and related securities, which resulted in a gain of $0.9 million related to the swaps to be recognized immediately. The gain was recorded in other noninterest income on the statement of operations. The Swap Agreements were based on three-month LIBOR and had original expiration dates in 2030 and 2031. Interest rate floors. In 2019, the Company entered into 20 interest rate floor agreements (the “Floor Agreements”) for a total notional amount of $400.0 million to hedge cash flow receipts on cash and securities or loans, if needed. The original Floor Agreements expire on various dates in April 2024 and July 2029. The Company utilizes one-month LIBOR and three-month LIBOR interest rate floors as hedges against adverse changes in cash flows on the designated cash, securities or loans attributable to fluctuations in the federal funds rate or three-month LIBOR below 2.50% or 2.25%, as applicable. The Floor Agreements were determined to be fully effective during all periods presented and, as such, no amount of ineffectiveness has been included in net income. The upfront fee paid to the counterparty in entering into these Floor Agreements was approximately $20.8 million. During the three months ended March 31, 2020, the Company sold $200.0 million of its total $400.0 million notional amount of interest rate floors for $13.0 million, which resulted in a net gain of $8.4 million, to be recognized over the weighted average remaining term of 4.1 years. The remaining agreements are one-month LIBOR floors with a strike price of 2.25% and expire in July 2029. Interest rate caps. In 2021, the Company entered into 26 interest rate cap agreements with a total notional amount of $552.8 million (“Federal Funds Rate Cap Agreements”). The Federal Funds Rate Cap Agreements are designated as fair value hedges against changes in the fair value of certain fixed rate tax-exempt municipal bonds. The Company utilizes the interest rate caps as hedges against adverse changes in interest rates on the designated securities attributable to fluctuations in the federal funds rate above 2.00%, as applicable. An increase in the benchmark interest rate hedged reduces the fair value of these assets. The Federal Funds Rate Cap Agreements expire on various dates from 2027 to 2032. The upfront fee paid to the counterparties was approximately $24.7 million. The Company expects the Federal Funds Rate Cap Agreements to remain effective during the remaining term of the respective agreements. During the three months ended March 31, 2022, the Company sold certain tax-exempt municipal bonds and $16.5 million notional amount of the related interest rate caps for $1.1 million in proceeds for the interest rate caps and recognized a gain of $0.4 million which was recognized immediately in other noninterest income on the statement of operations. In 2012, the Company entered into a $12.5 million and a $3.0 million notional forward interest rate cap agreement (the “LIBOR Cap Agreements”) to hedge its variable rate subordinated debentures. The $3.0 million LIBOR Cap Agreement matured during the three months ended March 31, 2022. The remaining $12.5 million LIBOR Cap Agreement expires July 25, 2022. The Company utilized these LIBOR Cap Agreements as hedges against adverse changes in cash flows attributable to fluctuations in three-month LIBOR beyond 0.50% for the $3.0 million subordinated debentures and six-month LIBOR beyond 0.75% for the $12.5 million subordinated debentures. The Cap Agreements were determined to be fully effective during all periods presented and, as such, no amount of ineffectiveness has been included in net income. The upfront fee paid to the counterparty in entering into these LIBOR Cap Agreements was approximately $2.5 million. The table below presents the fair value of the Company’s derivative financial instruments as well as the classification within the consolidated statements of financial condition. March 31, December 31, Balance Sheet Fair Value Balance Sheet Fair Value (Dollars in thousands) Derivatives designated as hedging instruments: Cash flow hedge interest rate floor Derivative assets $ 13,671 Derivative assets $ 18,992 Cash flow hedge interest rate cap Derivative assets — Derivative assets — Fair value hedge interest rate cap Derivative assets 32,744 Derivative assets 15,064 The following table presents the cumulative basis adjustments on hedged items designated as fair value hedges and the related amortized cost of those items as of the periods presented. Carrying Amount Cumulative Amount of Fair March 31, December 31, March 31, December 31, (Dollars in thousands) Line Item in the Statement of Financial Condition of Hedged Item: Securities available-for-sale $ 742,461 $ 697,437 $ (3,347) $ — The following table summarizes the effects of derivatives in cash flow and fair value hedging relationships designated as hedging instruments on the Company’s AOCI and consolidated statements of operations for the periods presented. Amount of Gain (Loss) Location of Gain (Loss) Amount of Gain (Loss) Three Months Ended Three Months Ended 2022 2021 2022 2021 (Dollars in thousands) Derivatives designated as hedging instruments: Cash flow hedge interest rate floor $ (857) $ (1,450) Interest income - Other interest earning assets $ 131 $ 136 Cash flow hedge interest rate floor (3,426) (5,800) Interest income - Taxable securities 1,032 1,052 Cash flow hedge interest rate cap — — Interest expense - Subordinated debentures (96) (99) Fair value hedge interest rate cap (1) 19,448 375 ________________________ (1) Represents amounts excluded from the assessment of effectiveness for which the difference between changes in fair value and periodic amortization is recorded in other comprehensive income. The Company estimates that approximately $1.6 million of net derivative gain for cash flow hedges included in AOCI will be reclassified into earnings within the next 12 months. No gain or loss was reclassified from AOCI into earnings as a result of forecasted transactions that failed to occur during the periods presented. The following table presents the effect of fair value hedge accounting on the Company’s consolidated statements of operations for the periods presented. Location and Amount of Gain or (Loss) Three Months Ended March 31, 2022 2021 Interest income - Taxable securities Interest income - Tax-exempt securities Interest income - Taxable securities Interest income - Tax-exempt securities (Dollars in thousands) Total interest income presented in the statement of operations in which the effects of fair value hedges are recorded $ 17,779 $ 13,184 $ 3,592 $ 1,695 Effects of fair value hedging relationships Interest rate contracts: Hedged items $ — $ (3,701) $ (1,072) $ (743) Derivatives designated as hedging instruments — 3,701 1,053 743 Amount excluded from effectiveness testing recognized in earnings based on amortization approach — (610) — (25) |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Comparison of the federal statutory income tax rates to the Company’s effective income tax rates for the periods presented are as follows: Three Months Ended March 31, 2022 2021 Amount Rate Amount Rate (Dollars in thousands) Statutory federal tax $ 7,222 21.0 % $ 2,415 21.0 % State tax, net of federal benefit 2,840 8.3 % (451) (3.9) % Tax credits (38) (0.1) % (41) (0.4) % Tax-exempt income, net (2,994) (8.7) % (347) (3.0) % Excess tax benefit from stock-based compensation (29) (0.1) % (3,003) (26.1) % Other items, net 14 0.0 % 216 1.9 % Actual tax expense (benefit) $ 7,015 20.4 % $ (1,211) (10.5) % Income tax expense was $7.0 million for the three months ended March 31, 2022 compared to a benefit of $1.2 million for the three months ended March 31, 2021. The effective tax rates for the three months ended March 31, 2022 and 2021 were 20.4% and (10.5)%, respectively. The tax expense and effective tax rate for the three months ended March 31, 2022 were reduced by a significant increase in tax-exempt income earned on certain municipal bonds compared to the three months ended March 31, 2021. The lower effective tax rate for the three months ended March 31, 2021 was due to higher excess tax benefits recognized on the exercise of stock options. The deferred tax asset balance as of March 31, 2022 was $97.1 million compared to $6.5 million as of December 31, 2021. The increase in the deferred tax asset is attributable to the unrealized losses on the available-for-sale securities portfolio. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Off-Balance Sheet Items In the normal course of business, the Company enters into various transactions, which, in accordance with GAAP, are not included in the consolidated statements of financial condition. The Company enters into these transactions to meet the financing needs of its customers. These transactions include commitments to extend credit and issue letters of credit, which involve, to varying degrees, elements of credit risk and interest rate risk exceeding the amounts recognized on the consolidated statements of financial condition. The Company’s exposure to credit loss is represented by the contractual amounts of these commitments. The same credit policies and procedures are used in making these commitments as for on-balance sheet instruments. The Company is not aware of any accounting loss to be incurred by funding these commitments, however, an allowance for off-balance sheet credit risk is recorded in other liabilities on the statements of financial condition. The allowance for these commitments amounted to approximately $1.6 million and $0.6 million at March 31, 2022 and December 31, 2021, respectively. The Company’s commitments associated with outstanding letters of credit and commitments to extend credit expiring by period as of the date indicated are summarized below. Since commitments associated with letters of credit and commitments to extend credit may expire unused, the amounts shown do not necessarily reflect the actual future cash funding requirements. March 31, December 31, (Dollars in thousands) Unfunded lines of credit $ 643,609 $ 248,092 Letters of credit 821 484 Total credit extension commitments $ 644,430 $ 248,576 Unfunded lines of credit represent unused credit facilities to the Company’s current borrowers that represent no change in credit risk that exist in the Company’s portfolio. Lines of credit generally have variable interest rates. Letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. In the event of nonperformance by the customer in accordance with the terms of the agreement with the third party, the Company would be required to fund the commitment. The maximum potential amount of future payments the Company could be required to make is represented by the contractual amount of the commitment. If the commitment is funded, the Company would be entitled to seek recovery from the client from the underlying collateral, which can include commercial real estate, physical plant and property, inventory, receivables, bitcoin, cash and/or marketable securities. The Company’s policies generally require that letter of credit arrangements contain security and debt covenants like those contained in loan agreements and our credit risk associated with issuing letters of credit is essentially the same as the risk involved in extending loan facilities to customers. The Company minimizes its exposure to loss under letters of credit and credit commitments by subjecting them to the same credit approval and monitoring procedures used for on-balance sheet instruments. The effect on the Company’s revenue, expenses, cash flows and liquidity of the unused portions of these letters of credit commitments cannot be precisely predicted because there is no guarantee that the lines of credit will be used. Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract, for a specific purpose. Commitments generally have variable interest rates, fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts disclosed above do not necessarily represent future cash requirements. The Company evaluates each customer’s credit worthiness on a case-by-case basis. The amount of collateral obtained if deemed necessary by the Company is based on management’s credit evaluation of the customer. Litigation The Company is involved in various matters of litigation which have arisen in the ordinary course of its business. In the opinion of management, the disposition of such pending litigation will not have a material adverse effect on the Company’s financial statements. |
Stock-based Compensation
Stock-based Compensation | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Stock-based Compensation | Stock-based Compensation In June 2018, the Company adopted the 2018 Equity Compensation Plan, or 2018 Plan, that permits the Compensation Committee, in its sole discretion, to grant various forms of incentive awards. Under the 2018 Plan, the Compensation Committee has the power to grant stock options, stock appreciation rights, or SARs, restricted stock and restricted stock units. The number of shares that may be issued pursuant to awards under the 2018 Plan is 1,596,753. In accordance with authoritative guidance for stock-based compensation, compensation expense is recognized only for those shares expected to vest, based on the Company’s historical experience and future expectations. The Company has elected a policy of estimating expected forfeitures. Total stock-based compensation expense was $0.7 million and $0.3 million for the three months ended March 31, 2022 and 2021, respectively. Stock Options A summary of stock option activity as of March 31, 2022 and changes during the three months ended March 31, 2022 is presented below: Number of Weighted Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2022 191,191 $ 24.97 Granted 29,117 110.84 Exercised (1,840) 16.09 Forfeited or expired (1,511) 16.09 Outstanding at March 31, 2022 216,957 $ 36.63 7.3 years $ 24,720 Exercisable at March 31, 2022 99,654 $ 19.28 6.0 years $ 13,083 Vested or Expected to Vest at March 31, 2022 209,715 $ 36.34 7.2 years $ 23,956 As of March 31, 2022, there was $2.2 million of total unrecognized compensation cost related to nonvested stock options which is expected to be recognized over a weighted-average period of 2.4 years. Restricted Stock Units A summary of the status of the Company’s nonvested restricted stock unit awards as of March 31, 2022, and changes during the three months ended March 31, 2022, is presented below: Number of Shares Weighted-Average Nonvested at January 1, 2022 56,871 $ 72.53 Granted 43,165 $ 110.84 Vested (7,128) $ 122.91 Forfeited (1,029) $ 71.99 Nonvested at March 31, 2022 91,879 $ 86.63 At March 31, 2022, there was approximately $6.1 million of total unrecognized compensation expense related to nonvested restricted stock unit awards, which is expected to be recognized over a weighted-average period of 2.6 years. |
Regulatory Capital
Regulatory Capital | 3 Months Ended |
Mar. 31, 2022 | |
Regulated Operations [Abstract] | |
Regulatory Capital | Regulatory Capital Banks and bank holding companies are subject to regulatory capital requirements administered by federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities, and certain off-balance-sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators. Failure to meet capital requirements can initiate regulatory action. The final rules implementing Basel Committee on Banking Supervision’s capital guidelines for U.S. banks (Basel III rules) became effective for the Company on January 1, 2015 with full compliance with all of the requirements being phased in over a multi-year schedule, and fully phased in by January 1, 2019. Under the Basel III rules, the Company must hold a capital conservation buffer above the adequately capitalized risk-based capital ratios. As of January 1, 2019, the capital conservation buffer had fully phased in to 2.50%. Inclusive of the fully phased-in capital conservation buffer, the common equity tier 1 capital ratio, tier 1 risk-based capital ratio and total risk-based capital ratio minimums are 7.00%, 8.50% and 10.50%, respectively. The Company and the Bank’s regulatory capital reflects the one-time AOCI opt-out election made in the first reporting period after it was subject to capital requirements and therefore the net unrealized gain or loss on available for sale securities and derivatives are not included in computing regulatory capital. Management believes, as of March 31, 2022, the Company and the Bank met all capital adequacy requirements to which they were subject. Prompt corrective action regulations provide five classifications: well capitalized, adequately capitalized, undercapitalized, significantly undercapitalized, and critically undercapitalized, although these terms are not used to represent overall financial condition. If adequately capitalized, regulatory approval is required to accept brokered deposits. If undercapitalized, capital distributions are limited, as is asset growth and expansion, and capital restoration plans are required. For the periods presented, the most recent regulatory notifications categorized the Bank as well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since that notification that management believes have changed the institution’s category. Actual capital amounts and ratios for the Company and the Bank as of March 31, 2022 and December 31, 2021, are presented in the following tables: Actual Minimum capital adequacy (1) To be well Amount Ratio Amount Ratio Amount Ratio (Dollars in thousands) March 31, 2022 The Company Tier 1 leverage ratio $ 1,597,946 9.68 % $ 660,633 4.00 % N/A N/A Common equity tier 1 capital ratio 1,388,825 38.97 % 160,360 4.50 % N/A N/A Tier 1 risk-based capital ratio 1,597,946 44.84 % 213,813 6.00 % N/A N/A Total risk-based capital ratio 1,603,983 45.01 % 285,084 8.00 % N/A N/A The Bank Tier 1 leverage ratio 1,577,199 9.51 % 663,196 4.00 % $ 828,995 5.00 % Common equity tier 1 capital ratio 1,577,199 44.28 % 160,273 4.50 % 231,505 6.50 % Tier 1 risk-based capital ratio 1,577,199 44.28 % 213,697 6.00 % 284,929 8.00 % Total risk-based capital ratio 1,583,236 44.45 % 284,929 8.00 % 356,161 10.00 % Actual Minimum capital adequacy (1) To be well Amount Ratio Amount Ratio Amount Ratio (Dollars in thousands) December 31, 2021 The Company Tier 1 leverage ratio $ 1,631,257 11.07 % $ 589,614 4.00 % N/A N/A Common equity tier 1 capital ratio 1,422,136 49.53 % 129,198 4.50 % N/A N/A Tier 1 risk-based capital ratio 1,631,257 56.82 % 172,264 6.00 % N/A N/A Total risk-based capital ratio 1,638,794 57.08 % 229,686 8.00 % N/A N/A The Bank Tier 1 leverage ratio 1,546,693 10.49 % 589,595 4.00 % $ 736,994 5.00 % Common equity tier 1 capital ratio 1,546,693 53.89 % 129,162 4.50 % 186,567 6.50 % Tier 1 risk-based capital ratio 1,546,693 53.89 % 172,216 6.00 % 229,622 8.00 % Total risk-based capital ratio 1,554,230 54.15 % 229,622 8.00 % 287,027 10.00 % ________________________ (1) Minimum capital adequacy for common equity tier 1 capital ratio, tier 1 risk-based capital ratio and total risk-based capital ratio excludes the capital conservation buffer. The Bank is restricted as to the amount of dividends that it can pay to the Company. Dividends declared in excess of the lesser of the Bank’s undivided profits or the Bank’s net income for its last three fiscal years less the amount of any distribution made to the Bank’s shareholder during the same period must be approved by the California DFPI. Also, the Bank may not pay dividends that would result in capital levels being reduced below the minimum requirements shown above. |
Fair Value
Fair Value | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Fair Value Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This standard’s fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1— Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2— Significant observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3— Significant unobservable inputs that reflect a Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. Financial Instruments Required To Be Carried At Fair Value The following is a description of valuation methodologies used for assets and liabilities recorded at fair value: Securities . The fair values of securities available-for-sale and trading securities are determined by obtaining quoted prices on nationally recognized securities exchanges (Level 1). For securities where quoted prices are not available, fair values are calculated based on market prices of similar securities (Level 2), using matrix pricing. Matrix pricing is a mathematical technique commonly used to price debt securities that are not actively traded, which values debt securities without relying exclusively on quoted prices for specific securities but rather by relying on the securities’ relationship to other benchmark quoted securities (Level 2 inputs). Derivatives . The Company’s derivative assets and liabilities are carried at fair value as required by GAAP. The estimated fair values of the derivative assets and liabilities are based on current market prices for similar instruments. Given the meaningful level of secondary market activity for derivative contracts, active pricing is available for similar assets and accordingly, the Company classifies its derivative assets and liabilities as Level 2. Impaired loans (collateral-dependent) . The Company does not record impaired loans at fair value on a recurring basis. However, from time to time, fair value adjustments are recorded on these loans to reflect (1) partial write-downs, through charge-offs or specific allowances, that are based on the current appraised or market-quoted value of the underlying collateral or (2) the full charge-off of the loan carrying value. In some cases, the properties for which market quotes or appraised values have been obtained are located in areas where comparable sales data is limited, outdated, or unavailable. Fair value estimates for collateral-dependent impaired loans are obtained from real estate brokers or other third-party consultants. These appraisals may utilize a single valuation approach or a combination of approaches, which generally include various Level 3 inputs. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available and such adjustments are typically significant. Appraisals may be adjusted by management for qualitative factors such as economic factors and estimated liquidation expenses. The range of these possible adjustments may vary. Impaired loans presented in the table below as of the periods presented include impaired loans with specific allowances as well as impaired loans that have been partially charged-off. The following tables provide the hierarchy and fair value for each class of assets and liabilities measured at fair value for the periods presented. As of March 31, 2022 and December 31, 2021, assets and liabilities measured at fair value on a recurring basis are as follows: Fair Value Measurements Using Quoted Prices Significant Other Significant Level 1 Level 2 Level 3 Total (Dollars in thousands) March 31, 2022 Assets Securities available-for-sale $ 176,343 $ 9,287,151 $ — $ 9,463,494 Derivative assets — 46,415 — 46,415 $ 176,343 $ 9,333,566 $ — $ 9,509,909 Fair Value Measurements Using Quoted Prices Significant Other Significant Level 1 Level 2 Level 3 Total (Dollars in thousands) December 31, 2021 Assets Securities available-for-sale $ — $ 8,625,259 $ — $ 8,625,259 Derivative assets — 34,056 — 34,056 $ — $ 8,659,315 $ — $ 8,659,315 There were no assets measured at fair value on a nonrecurring basis as of March 31, 2022 and December 31, 2021. Financial Instruments Not Required To Be Carried At Fair Value FASB ASC Topic 825, Financial Instruments , requires the disclosure of the estimated fair value of financial instruments. The Company’s estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to develop the estimates of fair value. Accordingly, the estimates are not necessarily indicative of the amounts the Company could have realized in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. The following tables present information about the Company’s assets and liabilities that are not measured at fair value in the consolidated statements of financial condition as of the dates presented: Carrying Fair Value Measurements Using Level 1 Level 2 Level 3 Total (Dollars in thousands) March 31, 2022 Financial assets: Cash and due from banks $ 207,304 $ 207,304 $ — $ — $ 207,304 Interest earning deposits 1,178,205 1,178,205 — — 1,178,205 Securities held-to-maturity 2,751,625 1,202,805 1,376,171 — 2,578,976 Loans held-for-sale 937,140 — 937,140 — 937,140 Loans held-for-investment, net 739,014 — — 742,784 742,784 Accrued interest receivable 62,573 158 17,070 45,345 62,573 Financial liabilities: Deposits $ 13,396,162 $ — $ 12,839,700 $ — $ 12,839,700 FHLB advances 800,000 — 800,000 — 800,000 Subordinated debentures, net 15,848 — 15,745 — 15,745 Accrued interest payable 111 — 111 — 111 Carrying Fair Value Measurements Using Level 1 Level 2 Level 3 Total (Dollars in thousands) December 31, 2021 Financial assets: Cash and due from banks $ 208,193 $ 208,193 $ — $ — $ 208,193 Interest earning deposits 5,179,753 5,179,753 — — 5,179,753 Loans held-for-sale 893,194 — 893,194 — 893,194 Loans held-for-investment, net 887,304 — — 891,166 891,166 Accrued interest receivable 40,370 41 8,980 31,349 40,370 Financial liabilities: Deposits $ 14,290,628 $ — $ 14,167,200 $ — $ 14,167,200 Subordinated debentures, net 15,845 — 15,646 — 15,646 Accrued interest payable 223 — 223 — 223 |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share The computation of basic and diluted earnings per share is shown below. Three Months Ended 2022 2021 (In thousands, except per share data) Basic Net income $ 27,386 $ 12,710 Less: Dividends paid to preferred shareholders 2,688 — Net income available to common shareholders $ 24,698 $ 12,710 Weighted average common shares outstanding 31,219 22,504 Basic earnings per common share $ 0.79 $ 0.56 Diluted Net income available to common shareholders $ 24,698 $ 12,710 Weighted average common shares outstanding for basic earnings per common share 31,219 22,504 Add: Dilutive effects of stock-based awards 182 506 Average shares and dilutive potential common shares 31,401 23,010 Dilutive earnings per common share $ 0.79 $ 0.55 Stock-based awards for 48,000 and 44,000 shares of common stock for the three months ended March 31, 2022 and 2021, respectively, were excluded from the computation of diluted earnings per share, because they were anti-dilutive. |
Shareholders' Equity
Shareholders' Equity | 3 Months Ended |
Mar. 31, 2022 | |
Equity [Abstract] | |
Shareholders' Equity | Shareholders’ Equity The Company’s Articles of Incorporation, as amended, or Articles, authorize the Company to issue up to (i) 125,000,000 shares of Class A Common Stock, par value $0.01 per share (“Class A Common Stock”), (ii) 25,000,000 shares of Class B Non-Voting Common Stock, par value $0.01 per share (“Class B Non-Voting Common Stock”), and (iii) 10,000,000 shares of Preferred Stock, par value $0.01 per share. Preferred Stock The Company, upon authorization of the board of directors, may issue shares of one or more series of preferred stock from time to time. The board of directors may, without any action by holders of Class A and Class B Common Stock or, except as may be otherwise provided in the terms of any series of preferred stock of which there are shares outstanding, holders of preferred stock adopt resolutions to designate and establish a new series of preferred stock. Upon establishing such a series of preferred stock, the board will determine the number of shares of preferred stock of that series that may be issued and the rights and preferences of that series of preferred stock. The rights of any series of preferred stock may include, among others, general or special voting rights; preferential liquidation or preemptive rights; preferential cumulative or noncumulative dividend rights; redemption or put rights; and conversion or exchange rights. On August 4, 2021, the Company issued and sold 8,000,000 depositary shares (the “Depositary Shares”), each representing a 1/40th interest in a share of 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, par value $0.01 per share (the “Series A Preferred Stock”), with a liquidation preference of $1,000 per share of Series A Preferred Stock, equivalent to $25 per Depositary Share. The aggregate gross proceeds of the offering were $200.0 million and net proceeds to the Company were approximately $193.6 million after deducting underwriting discounts and offering expenses. When, as and if declared by the board of directors of the Company, or a duly authorized board committee, dividends will be payable from the date of issuance, quarterly in arrears, beginning on November 15, 2021. The Company may redeem the Series A Preferred Stock at its option, subject to regulatory approval, on or after August 15, 2026. Preferred Stock Dividend On October 14, 2021, the Company’s Board of Directors declared the first quarterly dividend payment of $15.08 per share, equivalent to $0.377 per depositary share, on its Series A Preferred Stock, for the period covering August 4, 2021 through November 14, 2021 for a total dividend of $3.0 million. The depositary shares representing the Series A Preferred Stock are traded on the New York Stock Exchange under the symbol “SI PRA.” The dividend was paid on November 15, 2021 to shareholders of record of the preferred stock as of October 29, 2021. On January 14, 2022, the Company’s Board of Directors declared a quarterly dividend payment of $13.44 per share, equivalent to $0.336 per depositary share, on its Series A Preferred Stock, for the period covering November 15, 2021 through February 14, 2022 for a total dividend of $2.7 million. The depositary shares representing the Series A Preferred Stock are traded on the New York Stock Exchange under the symbol “SI PRA.” The dividend was paid on February 15, 2022 to shareholders of record of the preferred stock as of January 31, 2022. Common Stock Class A Voting Common Stock . Each holder of Class A Common Stock is entitled to one vote for each share on all matters submitted to a vote of shareholders, except as otherwise required by law and subject to the rights and preferences of the holders of any outstanding shares of our preferred stock. The members of the Company’s board of directors are elected by a plurality of the votes cast. The Company’s Articles expressly prohibit cumulative voting. Class B Non-Voting Common Stock. Class B Non-Voting Common Stock is non-voting while held by the initial holder with certain limited exceptions. Each share of Class B Non-Voting Common Stock will automatically convert into a share of Class A Common Stock upon certain sales or transfers by the initial holder of such shares including to an unaffiliated third-party and in a widely dispersed public offering. If Class B Non-Voting Common Stock is sold or transferred to an affiliate of the initial holder, the Class B Non-Voting Common Stock would not convert into Class A Common Stock. On January 26, 2021, the Company completed its underwritten public offering of 4,563,493 shares of Class A common stock at a price of $63.00 per share, including 595,238 shares of Class A common stock upon the exercise in full by the underwriters of their option to purchase additional shares. The aggregate gross proceeds of the offering were $287.5 million and net proceeds to the Company were $272.4 million after deducting underwriting discounts and offering expenses. On March 9, 2021, the Company entered into an equity distribution agreement pursuant to which the Company could issue and sell, from time to time, up to an aggregate gross sales price of $300.0 million of the Company’s shares of Class A common stock through an “at-the-market” equity offering program, or ATM Offering. As of June 30, 2021, the Company had completed the ATM Offering with a total of 2,793,826 shares of Class A common stock sold at an average price of $107.38. The transactions resulted in net proceeds to the Company of $295.1 million after deducting commissions and expenses. On December 9, 2021, the Company completed its underwritten public offering of 3,806,895 shares of Class A common stock at a price of $145.00 per share, including 496,551 shares of Class A common stock upon the exercise in full by the underwriters of their option to purchase additional shares. The aggregate gross proceeds of the offering were $552.0 million and net proceeds to the Company were $530.3 million after deducting underwriting discounts and offering expenses. On January 31, 2022 the Company issued 1,221,217 shares of the Company’s Class A common stock to the Sellers for the purchase of certain technology assets, at a price of $107.74 per share for a total value of $131.6 million. |
Subsequent Event
Subsequent Event | 3 Months Ended |
Mar. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Event | Subsequent Event Preferred Stock Dividend On April 11, 2022, the Company’s Board of Directors declared a quarterly dividend payment of $13.44 per share, equivalent to $0.336 per depositary share, on its Series A Preferred Stock, for the period covering February 15, 2022 through May 14, 2022, for a total dividend of $2.7 million. The depositary shares representing the Series A Preferred Stock are traded on the New York Stock Exchange under the symbol “SI PRA.” The dividend will be payable on May 16, 2022 to shareholders of record of the Series A Preferred Stock as of April 29, 2022. |
Nature of Business and Summar_2
Nature of Business and Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Financial Statement Preparation and Presentation | Financial Statement Preparation and Presentation The accompanying interim consolidated financial statements have been prepared by the Company, without an audit, in accordance with the instructions to the Quarterly Report on Form 10-Q, and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (the “SEC”) and, therefore, do not include all information and footnotes necessary for a fair presentation of its consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the unaudited financial information for the interim periods presented reflects all adjustments, consisting of only normal and recurring adjustments, necessary for a fair statement of the Company’s consolidated financial statements. These consolidated statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2021, included in the Company’s Annual Report on Form 10-K dated February 28, 2022. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. |
Consolidation | The consolidated financial statements include the accounts of the Company and all other entities in which it has a controlling financial interest. All significant intercompany accounts and transactions have been eliminated in consolidation. Unless the context requires otherwise, all references to the Company include its wholly owned subsidiaries. The accounting and reporting policies of the Company conform with GAAP and conform to predominant practices within the financial services industry. |
Use of Estimates | The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates. |
Recently Issued Accounting Pronouncements Not Yet Effective | Recently Issued Accounting Pronouncements Not Yet Effective In June 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (or “ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326) to replace the incurred loss model with an expected loss model, which is referred to as the current expected credit loss (or “CECL”) model. The CECL model is applicable to the measurement of credit losses on financial assets measured at amortized cost, including loan receivables, held to maturity debt securities, and reinsurance receivables. It also applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credit, financial guarantees, and other similar instruments) and net investments in leases recognized by a lessor. These amendments were initially effective for fiscal years beginning after December 15, 2019 for SEC registrants and after December 15, 2020, for Public Business Entities, or PBEs. In November 2019, the FASB issued ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates, which finalized the delay of the effective date for smaller reporting companies, as of the ASU 2019-10 effective date, such as the Company to apply the standards related to CECL, until fiscal years beginning after December 15, 2022. For debt securities with other than temporary impairment (OTTI), the guidance will be applied prospectively. The new methodology replaces the other-than-temporary impairment model and requires the recognition of an allowance for reductions in a security’s fair value attributable to declines in credit quality, instead of a direct write-down of the security when a valuation decline is determined to be other-than-temporary. Existing purchased credit impaired (PCI) assets will be grandfathered and classified as purchased credit deteriorated (PCD) assets at the date of adoption. The asset will be grossed up for the allowance for expected credit losses for all PCD assets at the date of adoption and will continue to recognize the noncredit discount in interest income based on the yield such assets as of the adoption date. Subsequent changes in expected credit losses will be recorded through the allowance. For all other assets with the scope of CECL, the cumulative effect adjustment will be recognized in retained earnings as of the beginning of the first reporting period in which the guidance is effective. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, which clarify that receivables arising from operating leases are not within the scope of Subtopic 326-20. Instead, impairment of receivables arising from operating leases should be accounted for in accordance with Topic 842, Leases. In March 2022, the FASB issued ASU 2022-02, Financial Instruments—Credit Losses (Topic 326), Troubled Debt Restructurings and Vintage Disclosures. The amendment eliminates the accounting guidance for troubled debt restructurings by creditors in Subtopic 310-40, while enhancing disclosure requirements for certain loan refinancings and restructuring by creditors when a borrow is experiencing financial difficulty. In addition, the update requires public business entities to disclose current-period gross write-offs for financing receivables and net investment in leases by year of origination. In relation to the loan portfolio, the Company formed a CECL implementation committee in 2018 which prepared a project plan to migrate towards the adoption date. As part of the project plan, the Company contracted a third-party vendor to assist in the application and analysis of ASU 2016-13 as well as a third party vendor to perform an independent model validation. As part of this process, the Company has determined preliminary loan pool segmentation under CECL, as well as evaluated the key economic loss drivers for each segment. The Company operationalized an initial CECL model during the second quarter of 2019 and is running this preliminary CECL model alongside the existing incurred loss methodology. The Company intends to continue to refine and run the model until the expected adoption date on January 1, 2023. The Company continues to evaluate the effects of ASU 2016-13 on its financial statements and disclosures. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (or “ASU 2020-04”), which provides temporary, optional guidance to ease the potential burden in accounting for, or recognizing the effects of, the transition away from the London Interbank Offered Rate (or “LIBOR”) or other interbank offered rate (reference rates) on financial reporting. On March 5, 2021, the U.K. Financial Conduct Authority, the regulatory supervisor for ICE Benchmark Administration, the administrator of LIBOR, announced that the overnight and one, three, six and twelve month USD LIBOR will be discontinued on June 30, 2023. It was originally expected that LIBOR would be discontinued by the end of 2021. To help with the transition to new reference rates, the ASU provides optional expedients and exceptions for applying GAAP to affected contract modifications and hedge accounting relationships. The guidance is applicable only to contracts or hedge accounting relationships that reference LIBOR or another reference rate expected to be discontinued. The expedients and exceptions in this update are available to all entities starting March 12, 2020 through December 31, 2022. In January 2020, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848), which clarifies the scope of Topic 848 to include derivative instruments impacted by discounting transition. The Company has created a subcommittee of the Asset Liability Management Committee to address the LIBOR transition and phase-out issues. The Company has identified its LIBOR-based contracts that will be impacted by the transition away from of LIBOR, and is incorporating fallback language in negotiated contracts and incorporating non-LIBOR reference rate and/or fallback language in new contracts to prepare for these changes. The Company is evaluating the impact that ASU 2020-04 will have on those financial assets where LIBOR is used as an index rate. In March 2022, the SEC released Staff Accounting Bulletin No. 121 (“SAB 121”), which provided interpretive guidance regarding accounting for obligations to safeguard crypto-assets an entity holds for platform users. The interpretive guidance requires an entity to recognize a liability on its balance sheet to reflect the obligation to safeguard the crypto-assets held for its platform users, along with a corresponding asset, both of which are measured at fair value. SAB 121 also requires disclosure of the nature and amount of crypto assets being safeguarded, how the fair value is determined, an entity’s accounting policy for safeguarding liabilities and corresponding assets and may require other information about risks and uncertainties arising from the entity’s safeguarding activities. SAB 121 is effective no later than the first interim or annual period ending after June 15, 2022, with retrospective application as of the beginning of the fiscal year. The Company is evaluating the impact that SAB 121 will have on its financial statements and disclosures. |
Financial Instruments Required To Be Carried At Fair Value | Financial Instruments Required To Be Carried At Fair Value The following is a description of valuation methodologies used for assets and liabilities recorded at fair value: Securities . The fair values of securities available-for-sale and trading securities are determined by obtaining quoted prices on nationally recognized securities exchanges (Level 1). For securities where quoted prices are not available, fair values are calculated based on market prices of similar securities (Level 2), using matrix pricing. Matrix pricing is a mathematical technique commonly used to price debt securities that are not actively traded, which values debt securities without relying exclusively on quoted prices for specific securities but rather by relying on the securities’ relationship to other benchmark quoted securities (Level 2 inputs). Derivatives . The Company’s derivative assets and liabilities are carried at fair value as required by GAAP. The estimated fair values of the derivative assets and liabilities are based on current market prices for similar instruments. Given the meaningful level of secondary market activity for derivative contracts, active pricing is available for similar assets and accordingly, the Company classifies its derivative assets and liabilities as Level 2. Impaired loans (collateral-dependent) . |
Securities (Tables)
Securities (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Securities and Gross Unrealized Gains and Losses | The following tables summarize the amortized cost, fair value of securities and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income and gross unrecognized gains and losses of available-for-sale and securities held-to-maturity at the dates indicated are as follows: March 31, 2022 Amortized Gross Gross Fair (Dollars in thousands) Available-for-sale securities U.S. Treasuries $ 34,889 $ — $ (165) $ 34,724 U.S. agency securities - excluding mortgage-backed securities 1,548,367 7,627 (7,333) 1,548,661 Residential mortgage-backed securities: Government agency mortgage-backed securities 1,781,961 62 (30,103) 1,751,920 Government agency collateralized mortgage obligation 1,385,198 1 (27,850) 1,357,349 Private-label collateralized mortgage obligation 1,342 12 (14) 1,340 Commercial mortgage-backed securities: Government agency mortgage-backed securities 1,338,333 2,360 (9,283) 1,331,410 Government agency collateralized mortgage obligation 70,839 — (60) 70,779 Private-label collateralized mortgage obligation 492,565 — (11,651) 480,914 Municipal bonds: Tax-exempt 2,900,600 65 (236,505) 2,664,160 Asset backed securities: Government sponsored student loan pools 226,738 — (4,501) 222,237 Total available-for-sale $ 9,780,832 $ 10,127 $ (327,465) $ 9,463,494 Amortized Gross Gross Fair (Dollars in thousands) Held-to-maturity securities U.S. Treasuries $ 1,245,293 $ — $ (42,488) $ 1,202,805 Residential mortgage-backed securities: Government agency mortgage-backed securities 547,423 — (34,896) 512,527 Government agency collateralized mortgage obligation 113,921 — (7,192) 106,729 Commercial mortgage-backed securities: Government agency collateralized mortgage obligation 53,408 — (5,179) 48,229 Municipal bonds: Tax-exempt 393,965 — (44,265) 349,700 Taxable 397,615 — (38,629) 358,986 Total held-to-maturity $ 2,751,625 $ — $ (172,649) $ 2,578,976 December 31, 2021 Amortized Gross Gross Fair (Dollars in thousands) Available-for-sale securities U.S. agency securities - excluding mortgage-backed securities $ 1,177,452 $ 7,320 $ (6,005) $ 1,178,767 Residential mortgage-backed securities: Government agency mortgage-backed securities 1,428,365 130 (14,378) 1,414,117 Government agency collateralized mortgage obligation 1,659,125 1,617 (15,739) 1,645,003 Private-label collateralized mortgage obligation 1,425 19 (11) 1,433 Commercial mortgage-backed securities: Government agency mortgage-backed securities 1,106,680 1,886 (4,962) 1,103,604 Government agency collateralized mortgage obligation 212,266 19 (1,370) 210,915 Private-label collateralized mortgage obligation 144,204 227 (797) 143,634 Municipal bonds: Tax-exempt 2,272,794 33,153 (8,210) 2,297,737 Taxable 403,279 341 (6,016) 397,604 Asset backed securities: Government sponsored student loan pools 233,374 97 (1,026) 232,445 Total available-for-sale $ 8,638,964 $ 44,809 $ (58,514) $ 8,625,259 |
Schedule of Securities with Unrealized Losses | Securities with unrealized and unrecognized losses as of the dates indicated, aggregated by investment category and length of time that individual securities have been in a continuous unrealized or unrecognized loss position, are as follows: March 31, 2022 Less than 12 Months 12 Months or More Total Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized (Dollars in thousands) Available-for-sale securities U.S. Treasuries $ 34,724 $ (165) $ — $ — $ 34,724 $ (165) U.S. agency securities - excluding mortgage-backed securities 781,759 (7,101) 12,977 (232) 794,736 (7,333) Residential mortgage-backed securities: Government agency mortgage-backed securities 1,725,830 (30,102) 68 (1) 1,725,898 (30,103) Government agency collateralized mortgage obligation 1,155,505 (24,377) 199,890 (3,473) 1,355,395 (27,850) Private-label collateralized mortgage obligation 199 (3) 421 (11) 620 (14) Commercial mortgage-backed securities: Government agency mortgage-backed securities 871,284 (9,283) — — 871,284 (9,283) Government agency collateralized mortgage obligation 62,991 (60) — — 62,991 (60) Private-label collateralized mortgage obligation 474,175 (11,513) 6,739 (138) 480,914 (11,651) Municipal bonds: Tax-exempt 2,627,812 (236,505) — — 2,627,812 (236,505) Asset backed securities: Government sponsored student loan pools 186,833 (4,054) 35,405 (447) 222,238 (4,501) $ 7,921,112 $ (323,163) $ 255,500 $ (4,302) $ 8,176,612 $ (327,465) Less than 12 Months 12 Months or More Total Fair Value Unrecognized Fair Value Unrecognized Fair Value Unrecognized (Dollars in thousands) Held-to-maturity securities U.S. Treasuries $ 1,202,805 $ (42,488) $ — $ — $ 1,202,805 $ (42,488) Residential mortgage-backed securities: Government agency mortgage-backed securities 512,527 (40,537) — — 512,527 (40,537) Government agency collateralized mortgage obligation 106,646 (10,393) — — 106,646 (10,393) Commercial mortgage-backed securities: Government agency collateralized mortgage obligation 48,229 (6,241) — — 48,229 (6,241) Municipal bonds: Tax-exempt 349,700 (48,038) — — 349,700 (48,038) Taxable 358,986 (44,164) — — 358,986 (44,164) $ 2,578,893 $ (191,861) $ — $ — $ 2,578,893 $ (191,861) December 31, 2021 Less than 12 Months 12 Months or More Total Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized (Dollars in thousands) Available-for-sale securities U.S. agency securities - excluding mortgage-backed securities $ 761,711 $ (6,005) $ — $ — $ 761,711 $ (6,005) Residential mortgage-backed securities: Government agency mortgage-backed securities 1,357,080 (14,378) 70 — 1,357,150 (14,378) Government agency collateralized mortgage obligation 1,513,388 (15,732) 650 (7) 1,514,038 (15,739) Private-label collateralized mortgage obligation — — 433 (11) 433 (11) Commercial mortgage-backed securities: Government agency mortgage-backed securities 435,055 (4,962) — — 435,055 (4,962) Government agency collateralized mortgage obligation 189,397 (1,370) — — 189,397 (1,370) Private-label collateralized mortgage obligation 98,173 (656) 6,791 (141) 104,964 (797) Municipal bonds: Tax-exempt 1,025,689 (8,210) — — 1,025,689 (8,210) Taxable 339,041 (6,016) — — 339,041 (6,016) Asset backed securities: Government sponsored student loan pools 168,204 (803) 32,783 (223) 200,987 (1,026) $ 5,887,738 $ (58,132) $ 40,727 $ (382) $ 5,928,465 $ (58,514) |
Schedule of Amortized Cost and Estimated Fair Value of Investment Securities by Contractual Maturity | The amortized cost and estimated fair value of investment securities as of the periods presented by contractual maturity are shown below. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. For purposes of the following table, the entire outstanding balance of residential and commercial mortgage-backed securities is categorized based on the final maturity date. March 31, December 31, Amortized Fair Amortized Fair (Dollars in thousands) Available-for-sale securities Within one year $ 34,889 $ 34,724 $ — $ — After one year through five years 1,611 1,531 2,243 2,170 After five years through ten years 1,503,068 1,502,618 1,406,395 1,401,733 After ten years 8,241,264 7,924,621 7,230,326 7,221,356 Total $ 9,780,832 $ 9,463,494 $ 8,638,964 $ 8,625,259 Held-to-maturity securities Within one year $ — $ — $ — $ — After one year through five years 1,245,293 1,202,805 — — After five years through ten years 275,375 249,523 — — After ten years 1,230,957 1,126,648 — — Total $ 2,751,625 $ 2,578,976 $ — $ — |
Loans (Tables)
Loans (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Receivables [Abstract] | |
Schedule of Loans | A summary of loans as of the periods presented are as follows: March 31, December 31, (Dollars in thousands) Real estate loans: One-to-four family $ 94,161 $ 105,098 Multi-family 9,368 56,751 Commercial 80,279 210,136 Construction — 7,573 Commercial and industrial 434,960 335,862 Reverse mortgage and other 1,137 1,410 Mortgage warehouse 125,435 177,115 Total gross loans held-for-investment 745,340 893,945 Deferred fees, net (1,884) 275 Total loans held-for-investment 743,456 894,220 Allowance for loan losses (4,442) (6,916) Total loans held-for-investment, net $ 739,014 $ 887,304 Total loans held-for-sale (1) $ 937,140 $ 893,194 ________________________ (1) Loans held-for-sale includes $914.2 million and $893.2 million of mortgage warehouse loans as of March 31, 2022 and December 31, 2021, respectively. |
Schedule of Allowance for Loan Losses | The following tables present the allocation of the allowance for loan losses, as well as the activity in the allowance by loan class, and recorded investment in loans held-for-investment as of and for the periods presented: Three Months Ended March 31, 2022 One-to Multi- Commercial Construction Commercial Reverse Mortgage Total (Dollars in thousands) Balance, December 31, 2021 $ 1,023 $ 682 $ 2,017 $ 776 $ 1,566 $ 12 $ 840 $ 6,916 Charge-offs — — — — — — — — Recoveries — — — — — — — — Provision for loan losses (223) (582) (1,542) (776) 933 (1) (283) (2,474) Balance, March 31, 2022 $ 800 $ 100 $ 475 $ — $ 2,499 $ 11 $ 557 $ 4,442 Three Months Ended March 31, 2021 One-to Multi- Commercial Construction Commercial and Reverse Mortgage Total (Dollars in thousands) Balance, December 31, 2020 $ 1,245 $ 878 $ 1,810 $ 590 $ 1,931 $ 39 $ 423 $ 6,916 Charge-offs — — — — — — — — Recoveries — — — — — — — — Provision for loan losses 389 (50) 1,441 (97) (1,571) (21) (91) — Balance, March 31, 2021 $ 1,634 $ 828 $ 3,251 $ 493 $ 360 $ 18 $ 332 $ 6,916 March 31, 2022 One-to Multi- Commercial Construction Commercial Reverse Mortgage Total (Dollars in thousands) Amount of allowance attributed to: Specifically evaluated impaired loans $ 28 $ — $ — $ — $ — $ — $ — $ 28 General portfolio allocation 772 100 475 — 2,499 11 557 4,414 Total allowance for loan losses $ 800 $ 100 $ 475 $ — $ 2,499 $ 11 $ 557 $ 4,442 Loans evaluated for impairment: Specifically evaluated $ 4,126 $ — $ 1,236 $ — $ — $ 646 $ — $ 6,008 Collectively evaluated 90,575 9,367 79,037 — 432,533 501 125,435 737,448 Total loans held-for-investment $ 94,701 $ 9,367 $ 80,273 $ — $ 432,533 $ 1,147 $ 125,435 $ 743,456 December 31, 2021 One-to Multi- Commercial Construction Commercial Reverse Mortgage Total (Dollars in thousands) Amount of allowance attributed to: Specifically evaluated impaired loans $ 29 $ — $ — $ — $ — $ — $ — $ 29 General portfolio allocation 994 682 2,017 776 1,566 12 840 6,887 Total allowance for loan losses $ 1,023 $ 682 $ 2,017 $ 776 $ 1,566 $ 12 $ 840 $ 6,916 Loans evaluated for impairment: Specifically evaluated $ 4,229 $ — $ 1,956 $ — $ — $ 923 $ — $ 7,108 Collectively evaluated 101,609 56,855 208,170 7,502 335,362 499 177,115 887,112 Total loans held-for-investment $ 105,838 $ 56,855 $ 210,126 $ 7,502 $ 335,362 $ 1,422 $ 177,115 $ 894,220 |
Schedule of Investments in Impaired Loans | The following tables provide a summary of the Company’s investment in impaired loans as of and for the periods presented: March 31, 2022 Unpaid Recorded Related (Dollars in thousands) With no related allowance recorded: Real estate loans: One-to-four family $ 3,866 $ 3,827 $ — Commercial 1,237 1,236 — Reverse mortgage and other 646 646 — 5,749 5,709 — With an allowance recorded: Real estate loans: One-to-four family 296 299 28 296 299 28 Total impaired loans $ 6,045 $ 6,008 $ 28 December 31, 2021 Unpaid Recorded Related (Dollars in thousands) With no related allowance recorded: Real estate loans: One-to-four family $ 4,616 $ 3,927 $ — Commercial 1,955 1,956 — Reverse mortgage and other 914 923 — 7,485 6,806 — With an allowance recorded: Real estate loans: One-to-four family 323 302 29 323 302 29 Total impaired loans $ 7,808 $ 7,108 $ 29 Three Months Ended March 31, 2022 2021 Average Interest Average Interest (Dollars in thousands) With no related allowance recorded: Real estate loans: One-to-four family $ 3,856 $ 17 $ 4,979 $ 77 Commercial 2,526 20 9,795 128 Commercial and industrial — — 249 5 Reverse mortgage and other 829 — 616 — 7,211 37 15,639 210 With an allowance recorded: Real estate loans: One-to-four family 300 1 64 1 Reverse mortgage and other — — 258 — 300 1 322 1 Total impaired loans $ 7,511 $ 38 $ 15,961 $ 211 |
Schedule of Aging Analysis by Loan Class | The following tables present by loan class the aging analysis based on contractual terms, nonaccrual loans, and the Company’s recorded investment in loans held-for-investment as of the periods presented: March 31, 2022 30-59 60-89 Greater Total Current Total Nonaccruing Loans (Dollars in thousands) Real estate loans: One-to-four family $ 210 $ 189 $ 2,776 $ 3,175 $ 91,526 $ 94,701 $ 2,986 $ — Multi-family — — — — 9,367 9,367 — — Commercial — — — — 80,273 80,273 — — Construction — — — — — — — — Commercial and industrial — — — — 432,533 432,533 — — Reverse mortgage and other — — — — 1,147 1,147 646 — Mortgage warehouse — — — — 125,435 125,435 — — Total loans held-for-investment $ 210 $ 189 $ 2,776 $ 3,175 $ 740,281 $ 743,456 $ 3,632 $ — December 31, 2021 30-59 60-89 Greater Total Current Total Nonaccruing Loans (Dollars in thousands) Real estate loans: One-to-four family $ 1,176 $ — $ 2,985 $ 4,161 $ 101,677 $ 105,838 $ 3,080 $ — Multi-family — — — — 56,855 56,855 — — Commercial — — — — 210,126 210,126 — — Construction — — — — 7,502 7,502 — — Commercial and industrial — — — — 335,362 335,362 — — Reverse mortgage and other — — — — 1,422 1,422 923 — Mortgage warehouse — — — — 177,115 177,115 — — Total loans held-for-investment $ 1,176 $ — $ 2,985 $ 4,161 $ 890,059 $ 894,220 $ 4,003 $ — |
Schedule of Financing Receivable Credit Quality Indicators Description | The Company uses the following definitions for risk ratings: Pass : Loans in all classes that are not adversely rated, are contractually current as to principal and interest, and are otherwise in compliance with the contractual terms of the loan agreement. Management believes that there is a low likelihood of loss related to those loans that are considered pass. Special mention : Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the institution’s credit position at some future date. Substandard : Loans classified as substandard are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected. Doubtful : Loans classified as doubtful have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Loss : Credits rated as loss are charged-off. Management has no expectation of the recovery of any payments in respect of credits rated as loss. |
Schedule of Financing Receivable Credit Quality Indicators | The following tables present by portfolio class the Company’s internal risk grading system as well as certain other information concerning the credit quality of the Company’s recorded investment in loans held-for-investment as of the periods presented. No assets were classified as loss or doubtful during the periods presented. Credit Risk Grades Pass Special Mention Substandard Doubtful Total (Dollars in thousands) March 31, 2022 Real estate loans: One-to-four family $ 91,166 $ 549 $ 2,986 $ — $ 94,701 Multi-family 9,367 — — — 9,367 Commercial 65,305 13,732 1,236 — 80,273 Construction — — — — — Commercial and industrial 432,533 — — — 432,533 Reverse mortgage and other 501 — 646 — 1,147 Mortgage warehouse 125,435 — — — 125,435 Total loans held-for-investment $ 724,307 $ 14,281 $ 4,868 $ — $ 743,456 Credit Risk Grades Pass Special Mention Substandard Doubtful Total (Dollars in thousands) December 31, 2021 Real estate loans: One-to-four family $ 102,307 $ 451 $ 3,080 $ — $ 105,838 Multi-family 56,855 — — — 56,855 Commercial 199,598 10,528 — — 210,126 Construction 7,502 — — — 7,502 Commercial and industrial 335,362 — — — 335,362 Reverse mortgage and other 499 — 923 — 1,422 Mortgage warehouse 177,115 — — — 177,115 Total loans held-for-investment $ 879,238 $ 10,979 $ 4,003 $ — $ 894,220 |
Schedule of Loans Held-for-Investment Purchased and/or Sold, by Portfolio Segment | Purchases and Sales The following table presents loans held-for-investment purchased and/or sold during the year by portfolio segment: Three Months Ended March 31, 2022 2021 Purchases Sales (1) Purchases Sales (Dollars in thousands) Real estate loans: Multi-family $ — $ 54,227 $ — $ — Commercial — 155,011 — — Construction — 6,823 — — $ — $ 216,061 $ — $ — ________________________ (1) In conjunction with the loan sale during the three months ended March 31, 2022, the Company purchased a participating interest of $67.6 million of the loans sold to the buyer. |
FHLB Advances and Other Borro_2
FHLB Advances and Other Borrowings (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of FHLB Advances | The following table sets forth certain information on our FHLB advances during the period presented: Three Months Ended Year Ended (Dollars in thousands) Amount outstanding at period-end $ 800,000 $ — Weighted average interest rate at period-end 0.43 % — |
Derivative and Hedging Activi_2
Derivative and Hedging Activities (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Fair Value of Derivative Financial Instruments and Classification within Statement of Financial Condition | The table below presents the fair value of the Company’s derivative financial instruments as well as the classification within the consolidated statements of financial condition. March 31, December 31, Balance Sheet Fair Value Balance Sheet Fair Value (Dollars in thousands) Derivatives designated as hedging instruments: Cash flow hedge interest rate floor Derivative assets $ 13,671 Derivative assets $ 18,992 Cash flow hedge interest rate cap Derivative assets — Derivative assets — Fair value hedge interest rate cap Derivative assets 32,744 Derivative assets 15,064 |
Schedule of Cumulative Basis Adjustments, Related Amortized Cost, and Effect of Fair Value Hedge Accounting | The following table presents the cumulative basis adjustments on hedged items designated as fair value hedges and the related amortized cost of those items as of the periods presented. Carrying Amount Cumulative Amount of Fair March 31, December 31, March 31, December 31, (Dollars in thousands) Line Item in the Statement of Financial Condition of Hedged Item: Securities available-for-sale $ 742,461 $ 697,437 $ (3,347) $ — The following table presents the effect of fair value hedge accounting on the Company’s consolidated statements of operations for the periods presented. Location and Amount of Gain or (Loss) Three Months Ended March 31, 2022 2021 Interest income - Taxable securities Interest income - Tax-exempt securities Interest income - Taxable securities Interest income - Tax-exempt securities (Dollars in thousands) Total interest income presented in the statement of operations in which the effects of fair value hedges are recorded $ 17,779 $ 13,184 $ 3,592 $ 1,695 Effects of fair value hedging relationships Interest rate contracts: Hedged items $ — $ (3,701) $ (1,072) $ (743) Derivatives designated as hedging instruments — 3,701 1,053 743 Amount excluded from effectiveness testing recognized in earnings based on amortization approach — (610) — (25) |
Schedule of Effects of Derivatives in Cash Flow and Fair Value Hedging Relationships on Accumulated Other Comprehensive Income (Loss) | The following table summarizes the effects of derivatives in cash flow and fair value hedging relationships designated as hedging instruments on the Company’s AOCI and consolidated statements of operations for the periods presented. Amount of Gain (Loss) Location of Gain (Loss) Amount of Gain (Loss) Three Months Ended Three Months Ended 2022 2021 2022 2021 (Dollars in thousands) Derivatives designated as hedging instruments: Cash flow hedge interest rate floor $ (857) $ (1,450) Interest income - Other interest earning assets $ 131 $ 136 Cash flow hedge interest rate floor (3,426) (5,800) Interest income - Taxable securities 1,032 1,052 Cash flow hedge interest rate cap — — Interest expense - Subordinated debentures (96) (99) Fair value hedge interest rate cap (1) 19,448 375 ________________________ (1) Represents amounts excluded from the assessment of effectiveness for which the difference between changes in fair value and periodic amortization is recorded in other comprehensive income. |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Effective Income Tax Rate Reconciliation | Comparison of the federal statutory income tax rates to the Company’s effective income tax rates for the periods presented are as follows: Three Months Ended March 31, 2022 2021 Amount Rate Amount Rate (Dollars in thousands) Statutory federal tax $ 7,222 21.0 % $ 2,415 21.0 % State tax, net of federal benefit 2,840 8.3 % (451) (3.9) % Tax credits (38) (0.1) % (41) (0.4) % Tax-exempt income, net (2,994) (8.7) % (347) (3.0) % Excess tax benefit from stock-based compensation (29) (0.1) % (3,003) (26.1) % Other items, net 14 0.0 % 216 1.9 % Actual tax expense (benefit) $ 7,015 20.4 % $ (1,211) (10.5) % |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Off-Balance Sheet Items | The Company’s commitments associated with outstanding letters of credit and commitments to extend credit expiring by period as of the date indicated are summarized below. Since commitments associated with letters of credit and commitments to extend credit may expire unused, the amounts shown do not necessarily reflect the actual future cash funding requirements. March 31, December 31, (Dollars in thousands) Unfunded lines of credit $ 643,609 $ 248,092 Letters of credit 821 484 Total credit extension commitments $ 644,430 $ 248,576 |
Stock-based Compensation (Table
Stock-based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Stock Option Activity | A summary of stock option activity as of March 31, 2022 and changes during the three months ended March 31, 2022 is presented below: Number of Weighted Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2022 191,191 $ 24.97 Granted 29,117 110.84 Exercised (1,840) 16.09 Forfeited or expired (1,511) 16.09 Outstanding at March 31, 2022 216,957 $ 36.63 7.3 years $ 24,720 Exercisable at March 31, 2022 99,654 $ 19.28 6.0 years $ 13,083 Vested or Expected to Vest at March 31, 2022 209,715 $ 36.34 7.2 years $ 23,956 |
Schedule of Status of Nonvested Restricted Stock Unit Awards and Changes | A summary of the status of the Company’s nonvested restricted stock unit awards as of March 31, 2022, and changes during the three months ended March 31, 2022, is presented below: Number of Shares Weighted-Average Nonvested at January 1, 2022 56,871 $ 72.53 Granted 43,165 $ 110.84 Vested (7,128) $ 122.91 Forfeited (1,029) $ 71.99 Nonvested at March 31, 2022 91,879 $ 86.63 |
Regulatory Capital (Tables)
Regulatory Capital (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Regulated Operations [Abstract] | |
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations | Actual capital amounts and ratios for the Company and the Bank as of March 31, 2022 and December 31, 2021, are presented in the following tables: Actual Minimum capital adequacy (1) To be well Amount Ratio Amount Ratio Amount Ratio (Dollars in thousands) March 31, 2022 The Company Tier 1 leverage ratio $ 1,597,946 9.68 % $ 660,633 4.00 % N/A N/A Common equity tier 1 capital ratio 1,388,825 38.97 % 160,360 4.50 % N/A N/A Tier 1 risk-based capital ratio 1,597,946 44.84 % 213,813 6.00 % N/A N/A Total risk-based capital ratio 1,603,983 45.01 % 285,084 8.00 % N/A N/A The Bank Tier 1 leverage ratio 1,577,199 9.51 % 663,196 4.00 % $ 828,995 5.00 % Common equity tier 1 capital ratio 1,577,199 44.28 % 160,273 4.50 % 231,505 6.50 % Tier 1 risk-based capital ratio 1,577,199 44.28 % 213,697 6.00 % 284,929 8.00 % Total risk-based capital ratio 1,583,236 44.45 % 284,929 8.00 % 356,161 10.00 % Actual Minimum capital adequacy (1) To be well Amount Ratio Amount Ratio Amount Ratio (Dollars in thousands) December 31, 2021 The Company Tier 1 leverage ratio $ 1,631,257 11.07 % $ 589,614 4.00 % N/A N/A Common equity tier 1 capital ratio 1,422,136 49.53 % 129,198 4.50 % N/A N/A Tier 1 risk-based capital ratio 1,631,257 56.82 % 172,264 6.00 % N/A N/A Total risk-based capital ratio 1,638,794 57.08 % 229,686 8.00 % N/A N/A The Bank Tier 1 leverage ratio 1,546,693 10.49 % 589,595 4.00 % $ 736,994 5.00 % Common equity tier 1 capital ratio 1,546,693 53.89 % 129,162 4.50 % 186,567 6.50 % Tier 1 risk-based capital ratio 1,546,693 53.89 % 172,216 6.00 % 229,622 8.00 % Total risk-based capital ratio 1,554,230 54.15 % 229,622 8.00 % 287,027 10.00 % ________________________ (1) Minimum capital adequacy for common equity tier 1 capital ratio, tier 1 risk-based capital ratio and total risk-based capital ratio excludes the capital conservation buffer. |
Fair Value (Tables)
Fair Value (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis | As of March 31, 2022 and December 31, 2021, assets and liabilities measured at fair value on a recurring basis are as follows: Fair Value Measurements Using Quoted Prices Significant Other Significant Level 1 Level 2 Level 3 Total (Dollars in thousands) March 31, 2022 Assets Securities available-for-sale $ 176,343 $ 9,287,151 $ — $ 9,463,494 Derivative assets — 46,415 — 46,415 $ 176,343 $ 9,333,566 $ — $ 9,509,909 Fair Value Measurements Using Quoted Prices Significant Other Significant Level 1 Level 2 Level 3 Total (Dollars in thousands) December 31, 2021 Assets Securities available-for-sale $ — $ 8,625,259 $ — $ 8,625,259 Derivative assets — 34,056 — 34,056 $ — $ 8,659,315 $ — $ 8,659,315 |
Schedule of Fair Value by Balance Sheet Grouping | The following tables present information about the Company’s assets and liabilities that are not measured at fair value in the consolidated statements of financial condition as of the dates presented: Carrying Fair Value Measurements Using Level 1 Level 2 Level 3 Total (Dollars in thousands) March 31, 2022 Financial assets: Cash and due from banks $ 207,304 $ 207,304 $ — $ — $ 207,304 Interest earning deposits 1,178,205 1,178,205 — — 1,178,205 Securities held-to-maturity 2,751,625 1,202,805 1,376,171 — 2,578,976 Loans held-for-sale 937,140 — 937,140 — 937,140 Loans held-for-investment, net 739,014 — — 742,784 742,784 Accrued interest receivable 62,573 158 17,070 45,345 62,573 Financial liabilities: Deposits $ 13,396,162 $ — $ 12,839,700 $ — $ 12,839,700 FHLB advances 800,000 — 800,000 — 800,000 Subordinated debentures, net 15,848 — 15,745 — 15,745 Accrued interest payable 111 — 111 — 111 Carrying Fair Value Measurements Using Level 1 Level 2 Level 3 Total (Dollars in thousands) December 31, 2021 Financial assets: Cash and due from banks $ 208,193 $ 208,193 $ — $ — $ 208,193 Interest earning deposits 5,179,753 5,179,753 — — 5,179,753 Loans held-for-sale 893,194 — 893,194 — 893,194 Loans held-for-investment, net 887,304 — — 891,166 891,166 Accrued interest receivable 40,370 41 8,980 31,349 40,370 Financial liabilities: Deposits $ 14,290,628 $ — $ 14,167,200 $ — $ 14,167,200 Subordinated debentures, net 15,845 — 15,646 — 15,646 Accrued interest payable 223 — 223 — 223 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Earnings Per Share | The computation of basic and diluted earnings per share is shown below. Three Months Ended 2022 2021 (In thousands, except per share data) Basic Net income $ 27,386 $ 12,710 Less: Dividends paid to preferred shareholders 2,688 — Net income available to common shareholders $ 24,698 $ 12,710 Weighted average common shares outstanding 31,219 22,504 Basic earnings per common share $ 0.79 $ 0.56 Diluted Net income available to common shareholders $ 24,698 $ 12,710 Weighted average common shares outstanding for basic earnings per common share 31,219 22,504 Add: Dilutive effects of stock-based awards 182 506 Average shares and dilutive potential common shares 31,401 23,010 Dilutive earnings per common share $ 0.79 $ 0.55 |
Securities - Reconciliation fro
Securities - Reconciliation from Amortized Cost to Estimated Fair Value (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Available-for-sale securities | ||
Amortized Cost | $ 9,780,832 | $ 8,638,964 |
Gross Unrealized Gains | 10,127 | 44,809 |
Gross Unrealized Losses | (327,465) | (58,514) |
Fair Value | 9,463,494 | 8,625,259 |
Held-to-maturity securities | ||
Amortized Cost | 2,751,625 | 0 |
Gross Unrecognized Gains | 0 | |
Gross Unrecognized Losses | (172,649) | |
Fair Value | 2,578,976 | |
U.S. Treasuries | ||
Available-for-sale securities | ||
Amortized Cost | 34,889 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | (165) | |
Fair Value | 34,724 | |
Held-to-maturity securities | ||
Amortized Cost | 1,245,293 | |
Gross Unrecognized Gains | 0 | |
Gross Unrecognized Losses | (42,488) | |
Fair Value | 1,202,805 | |
U.S. agency securities - excluding mortgage-backed securities | ||
Available-for-sale securities | ||
Amortized Cost | 1,548,367 | 1,177,452 |
Gross Unrealized Gains | 7,627 | 7,320 |
Gross Unrealized Losses | (7,333) | (6,005) |
Fair Value | 1,548,661 | 1,178,767 |
Government agency mortgage-backed securities | ||
Available-for-sale securities | ||
Amortized Cost | 1,781,961 | 1,428,365 |
Gross Unrealized Gains | 62 | 130 |
Gross Unrealized Losses | (30,103) | (14,378) |
Fair Value | 1,751,920 | 1,414,117 |
Held-to-maturity securities | ||
Amortized Cost | 547,423 | |
Gross Unrecognized Gains | 0 | |
Gross Unrecognized Losses | (34,896) | |
Fair Value | 512,527 | |
Government agency collateralized mortgage obligation | ||
Available-for-sale securities | ||
Amortized Cost | 1,385,198 | 1,659,125 |
Gross Unrealized Gains | 1 | 1,617 |
Gross Unrealized Losses | (27,850) | (15,739) |
Fair Value | 1,357,349 | 1,645,003 |
Held-to-maturity securities | ||
Amortized Cost | 113,921 | |
Gross Unrecognized Gains | 0 | |
Gross Unrecognized Losses | (7,192) | |
Fair Value | 106,729 | |
Private-label collateralized mortgage obligation | ||
Available-for-sale securities | ||
Amortized Cost | 1,342 | 1,425 |
Gross Unrealized Gains | 12 | 19 |
Gross Unrealized Losses | (14) | (11) |
Fair Value | 1,340 | 1,433 |
Government agency mortgage-backed securities | ||
Available-for-sale securities | ||
Amortized Cost | 1,338,333 | 1,106,680 |
Gross Unrealized Gains | 2,360 | 1,886 |
Gross Unrealized Losses | (9,283) | (4,962) |
Fair Value | 1,331,410 | 1,103,604 |
Government agency collateralized mortgage obligation | ||
Available-for-sale securities | ||
Amortized Cost | 70,839 | 212,266 |
Gross Unrealized Gains | 0 | 19 |
Gross Unrealized Losses | (60) | (1,370) |
Fair Value | 70,779 | 210,915 |
Held-to-maturity securities | ||
Amortized Cost | 53,408 | |
Gross Unrecognized Gains | 0 | |
Gross Unrecognized Losses | (5,179) | |
Fair Value | 48,229 | |
Private-label collateralized mortgage obligation | ||
Available-for-sale securities | ||
Amortized Cost | 492,565 | 144,204 |
Gross Unrealized Gains | 0 | 227 |
Gross Unrealized Losses | (11,651) | (797) |
Fair Value | 480,914 | 143,634 |
Tax-exempt | ||
Available-for-sale securities | ||
Amortized Cost | 2,900,600 | 2,272,794 |
Gross Unrealized Gains | 65 | 33,153 |
Gross Unrealized Losses | (236,505) | (8,210) |
Fair Value | 2,664,160 | 2,297,737 |
Held-to-maturity securities | ||
Amortized Cost | 393,965 | |
Gross Unrecognized Gains | 0 | |
Gross Unrecognized Losses | (44,265) | |
Fair Value | 349,700 | |
Taxable | ||
Available-for-sale securities | ||
Amortized Cost | 403,279 | |
Gross Unrealized Gains | 341 | |
Gross Unrealized Losses | (6,016) | |
Fair Value | 397,604 | |
Held-to-maturity securities | ||
Amortized Cost | 397,615 | |
Gross Unrecognized Gains | 0 | |
Gross Unrecognized Losses | (38,629) | |
Fair Value | 358,986 | |
Government sponsored student loan pools | ||
Available-for-sale securities | ||
Amortized Cost | 226,738 | 233,374 |
Gross Unrealized Gains | 0 | 97 |
Gross Unrealized Losses | (4,501) | (1,026) |
Fair Value | $ 222,237 | $ 232,445 |
Securities - Narrative (Details
Securities - Narrative (Details) | 3 Months Ended | ||
Mar. 31, 2022USD ($)issuersecurity | Mar. 31, 2021USD ($) | Dec. 31, 2021USD ($)security | |
Investments, Debt and Equity Securities [Abstract] | |||
Fair value of available-for-sale securities, transferred to held-to-maturity | $ 1,500,000,000 | ||
Available-for-sale securities, transferred to held-to-maturity, cumulative unrecognized loss, after tax | 14,100,000 | ||
Investment securities pledged for borrowings | $ 1,200,000,000 | $ 0 | |
Fair value of securities issued in an amount greater than 10% of shareholders' equity, number of individual issuers | issuer | 1 | ||
Fair value of securities issued in an amount greater than 10% of shareholders' equity | $ 275,300,000 | ||
Gross unrealized losses on available-for-sale and held-to-maturity securities in a continuous unrealized loss position | 519,300,000 | ||
Gross unrealized losses on available-for-sale securities in a continuous unrealized loss position | $ 327,465,000 | $ 58,514,000 | |
Number of securities whose estimated fair value declined | security | 622 | 323 | |
Decline in fair value from amortized cost (as a percent) | 4.61% | 0.98% | |
Proceeds from sale of securities available-for-sale | $ 432,059,000 | $ 0 | |
Realized gain on available-for-sale securities | 3,800,000 | ||
Realized loss on available-for-sale securities | 4,400,000 | ||
Credit losses recognized in earnings | $ 0 | $ 0 |
Securities - Securities in Unre
Securities - Securities in Unrealized Loss Position (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Fair Value | ||
Less than 12 Months | $ 7,921,112 | $ 5,887,738 |
12 Months or More | 255,500 | 40,727 |
Total | 8,176,612 | 5,928,465 |
Unrealized Losses | ||
Less than 12 Months | (323,163) | (58,132) |
12 Months or More | (4,302) | (382) |
Total | (327,465) | (58,514) |
Fair Value | ||
Less than 12 Months | 2,578,893 | |
12 Months or More | 0 | |
Total | 2,578,893 | |
Unrealized Losses | ||
Less than 12 Months | (191,861) | |
12 Months or More | 0 | |
Total | (191,861) | |
U.S. Treasuries | ||
Fair Value | ||
Less than 12 Months | 34,724 | |
12 Months or More | 0 | |
Total | 34,724 | |
Unrealized Losses | ||
Less than 12 Months | (165) | |
12 Months or More | 0 | |
Total | (165) | |
Fair Value | ||
Less than 12 Months | 1,202,805 | |
12 Months or More | 0 | |
Total | 1,202,805 | |
Unrealized Losses | ||
Less than 12 Months | (42,488) | |
12 Months or More | 0 | |
Total | (42,488) | |
U.S. agency securities - excluding mortgage-backed securities | ||
Fair Value | ||
Less than 12 Months | 781,759 | 761,711 |
12 Months or More | 12,977 | 0 |
Total | 794,736 | 761,711 |
Unrealized Losses | ||
Less than 12 Months | (7,101) | (6,005) |
12 Months or More | (232) | 0 |
Total | (7,333) | (6,005) |
Government agency mortgage-backed securities | ||
Fair Value | ||
Less than 12 Months | 1,725,830 | 1,357,080 |
12 Months or More | 68 | 70 |
Total | 1,725,898 | 1,357,150 |
Unrealized Losses | ||
Less than 12 Months | (30,102) | (14,378) |
12 Months or More | (1) | 0 |
Total | (30,103) | (14,378) |
Fair Value | ||
Less than 12 Months | 512,527 | |
12 Months or More | 0 | |
Total | 512,527 | |
Unrealized Losses | ||
Less than 12 Months | (40,537) | |
12 Months or More | 0 | |
Total | (40,537) | |
Government agency collateralized mortgage obligation | ||
Fair Value | ||
Less than 12 Months | 1,155,505 | 1,513,388 |
12 Months or More | 199,890 | 650 |
Total | 1,355,395 | 1,514,038 |
Unrealized Losses | ||
Less than 12 Months | (24,377) | (15,732) |
12 Months or More | (3,473) | (7) |
Total | (27,850) | (15,739) |
Fair Value | ||
Less than 12 Months | 106,646 | |
12 Months or More | 0 | |
Total | 106,646 | |
Unrealized Losses | ||
Less than 12 Months | (10,393) | |
12 Months or More | 0 | |
Total | (10,393) | |
Private-label collateralized mortgage obligation | ||
Fair Value | ||
Less than 12 Months | 199 | 0 |
12 Months or More | 421 | 433 |
Total | 620 | 433 |
Unrealized Losses | ||
Less than 12 Months | (3) | 0 |
12 Months or More | (11) | (11) |
Total | (14) | (11) |
Government agency mortgage-backed securities | ||
Fair Value | ||
Less than 12 Months | 871,284 | 435,055 |
12 Months or More | 0 | 0 |
Total | 871,284 | 435,055 |
Unrealized Losses | ||
Less than 12 Months | (9,283) | (4,962) |
12 Months or More | 0 | 0 |
Total | (9,283) | (4,962) |
Government agency collateralized mortgage obligation | ||
Fair Value | ||
Less than 12 Months | 62,991 | 189,397 |
12 Months or More | 0 | 0 |
Total | 62,991 | 189,397 |
Unrealized Losses | ||
Less than 12 Months | (60) | (1,370) |
12 Months or More | 0 | 0 |
Total | (60) | (1,370) |
Fair Value | ||
Less than 12 Months | 48,229 | |
12 Months or More | 0 | |
Total | 48,229 | |
Unrealized Losses | ||
Less than 12 Months | (6,241) | |
12 Months or More | 0 | |
Total | (6,241) | |
Private-label collateralized mortgage obligation | ||
Fair Value | ||
Less than 12 Months | 474,175 | 98,173 |
12 Months or More | 6,739 | 6,791 |
Total | 480,914 | 104,964 |
Unrealized Losses | ||
Less than 12 Months | (11,513) | (656) |
12 Months or More | (138) | (141) |
Total | (11,651) | (797) |
Tax-exempt | ||
Fair Value | ||
Less than 12 Months | 2,627,812 | 1,025,689 |
12 Months or More | 0 | 0 |
Total | 2,627,812 | 1,025,689 |
Unrealized Losses | ||
Less than 12 Months | (236,505) | (8,210) |
12 Months or More | 0 | 0 |
Total | (236,505) | (8,210) |
Fair Value | ||
Less than 12 Months | 349,700 | |
12 Months or More | 0 | |
Total | 349,700 | |
Unrealized Losses | ||
Less than 12 Months | (48,038) | |
12 Months or More | 0 | |
Total | (48,038) | |
Taxable | ||
Fair Value | ||
Less than 12 Months | 339,041 | |
12 Months or More | 0 | |
Total | 339,041 | |
Unrealized Losses | ||
Less than 12 Months | (6,016) | |
12 Months or More | 0 | |
Total | (6,016) | |
Fair Value | ||
Less than 12 Months | 358,986 | |
12 Months or More | 0 | |
Total | 358,986 | |
Unrealized Losses | ||
Less than 12 Months | (44,164) | |
12 Months or More | 0 | |
Total | (44,164) | |
Government sponsored student loan pools | ||
Fair Value | ||
Less than 12 Months | 186,833 | 168,204 |
12 Months or More | 35,405 | 32,783 |
Total | 222,238 | 200,987 |
Unrealized Losses | ||
Less than 12 Months | (4,054) | (803) |
12 Months or More | (447) | (223) |
Total | $ (4,501) | $ (1,026) |
Securities - Amortized Cost and
Securities - Amortized Cost and Estimated Fair Value of Investment Securities by Contractual Maturity (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Amortized Cost | ||
Within one year | $ 34,889 | $ 0 |
After one year through five years | 1,611 | 2,243 |
After five years through ten years | 1,503,068 | 1,406,395 |
After ten years | 8,241,264 | 7,230,326 |
Total | 9,780,832 | 8,638,964 |
Fair Value | ||
Within one year | 34,724 | 0 |
After one year through five years | 1,531 | 2,170 |
After five years through ten years | 1,502,618 | 1,401,733 |
After ten years | 7,924,621 | 7,221,356 |
Total | 9,463,494 | 8,625,259 |
Amortized Cost | ||
Within one year | 0 | 0 |
After one year through five years | 1,245,293 | 0 |
After five years through ten years | 275,375 | 0 |
After ten years | 1,230,957 | 0 |
Total | 2,751,625 | 0 |
Fair Value | ||
Within one year | 0 | 0 |
After one year through five years | 1,202,805 | 0 |
After five years through ten years | 249,523 | 0 |
After ten years | 1,126,648 | 0 |
Total | $ 2,578,976 | $ 0 |
Loans - Narrative (Details)
Loans - Narrative (Details) | 3 Months Ended | ||
Mar. 31, 2022USD ($)contract | Mar. 31, 2021USD ($)contract | Dec. 31, 2021USD ($) | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total gross loans held-for-investment | $ 745,340,000 | $ 893,945,000 | |
Accrued interest on loans held-for-investment | 2,500,000 | 3,300,000 | |
Investment in TDRs | 1,700,000 | 1,700,000 | |
Allowance allocated to investment in TDRs | $ 28,000 | 29,000 | |
Loans modified as TDRs | contract | 0 | 0 | |
Loans modified as TDRs, subsequent default | contract | 0 | 0 | |
Provision for loan loss for TDRs that subsequently defaulted | $ 0 | $ 0 | |
Related party loans | 0 | 7,700,000 | |
Decrease in balance of related party loans due to principal payments received | 7,700,000 | ||
Real Estate | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total gross loans held-for-investment | 184,900,000 | 381,000,000 | |
SEN Leverage | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total gross loans held-for-investment | 435,000,000 | 335,900,000 | |
SEN Leverage, Unfunded Loan Commitment | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total gross loans held-for-investment | 635,100,000 | 234,600,000 | |
Mortgage warehouse | Residential | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total gross loans held-for-investment | 125,435,000 | 177,115,000 | |
Gross mortgage warehouse loans | $ 1,000,000,000 | $ 1,100,000,000 |
Loans - Summary of Loans (Detai
Loans - Summary of Loans (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | $ 745,340 | $ 893,945 | ||
Deferred fees, net | (1,884) | 275 | ||
Total loans held-for-investment | 743,456 | 894,220 | ||
Allowance for loan losses | (4,442) | (6,916) | $ (6,916) | $ (6,916) |
Total loans held-for-investment, net | 739,014 | 887,304 | ||
Total loans held-for-sale | 937,140 | 893,194 | ||
Residential | Mortgage warehouse | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | 125,435 | 177,115 | ||
Total loans held-for-investment | 125,435 | 177,115 | ||
Allowance for loan losses | (557) | (840) | (332) | (423) |
Total loans held-for-sale | 914,200 | 893,200 | ||
Reverse mortgage and other | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | 1,137 | 1,410 | ||
Total loans held-for-investment | 1,147 | 1,422 | ||
Allowance for loan losses | (11) | (12) | (18) | (39) |
Real estate loans | Residential | One-to-four family | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | 94,161 | 105,098 | ||
Total loans held-for-investment | 94,701 | 105,838 | ||
Allowance for loan losses | (800) | (1,023) | (1,634) | (1,245) |
Real estate loans | Residential | Multi-family | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | 9,368 | 56,751 | ||
Total loans held-for-investment | 9,367 | 56,855 | ||
Allowance for loan losses | (100) | (682) | (828) | (878) |
Real estate loans | Commercial | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | 80,279 | 210,136 | ||
Total loans held-for-investment | 80,273 | 210,126 | ||
Allowance for loan losses | (475) | (2,017) | (3,251) | (1,810) |
Real estate loans | Commercial | Construction | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | 0 | 7,573 | ||
Total loans held-for-investment | 0 | 7,502 | ||
Allowance for loan losses | 0 | (776) | (493) | (590) |
Commercial and industrial | Commercial and industrial | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Total gross loans held-for-investment | 434,960 | 335,862 | ||
Total loans held-for-investment | 432,533 | 335,362 | ||
Allowance for loan losses | $ (2,499) | $ (1,566) | $ (360) | $ (1,931) |
Loans - Allowance (Details)
Loans - Allowance (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | $ 6,916 | $ 6,916 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | (2,474) | 0 | |
Ending balance | 4,442 | 6,916 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 28 | $ 29 | |
General portfolio allocation | 4,414 | 6,887 | |
Total allowance for loan losses | 4,442 | 6,916 | 6,916 |
Loans evaluated for impairment: | |||
Specifically evaluated | 6,008 | 7,108 | |
Collectively evaluated | 737,448 | 887,112 | |
Total loans held-for-investment | 743,456 | 894,220 | |
Residential | One-to-four family | Real estate loans | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | 1,023 | 1,245 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | (223) | 389 | |
Ending balance | 800 | 1,634 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 28 | 29 | |
General portfolio allocation | 772 | 994 | |
Total allowance for loan losses | 800 | 1,634 | 1,023 |
Loans evaluated for impairment: | |||
Specifically evaluated | 4,126 | 4,229 | |
Collectively evaluated | 90,575 | 101,609 | |
Total loans held-for-investment | 94,701 | 105,838 | |
Residential | Multi- Family | Real estate loans | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | 682 | 878 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | (582) | (50) | |
Ending balance | 100 | 828 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 0 | 0 | |
General portfolio allocation | 100 | 682 | |
Total allowance for loan losses | 100 | 828 | 682 |
Loans evaluated for impairment: | |||
Specifically evaluated | 0 | 0 | |
Collectively evaluated | 9,367 | 56,855 | |
Total loans held-for-investment | 9,367 | 56,855 | |
Residential | Mortgage Warehouse | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | 840 | 423 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | (283) | (91) | |
Ending balance | 557 | 332 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 0 | 0 | |
General portfolio allocation | 557 | 840 | |
Total allowance for loan losses | 557 | 332 | 840 |
Loans evaluated for impairment: | |||
Specifically evaluated | 0 | 0 | |
Collectively evaluated | 125,435 | 177,115 | |
Total loans held-for-investment | 125,435 | 177,115 | |
Commercial | Real estate loans | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | 2,017 | 1,810 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | (1,542) | 1,441 | |
Ending balance | 475 | 3,251 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 0 | 0 | |
General portfolio allocation | 475 | 2,017 | |
Total allowance for loan losses | 475 | 3,251 | 2,017 |
Loans evaluated for impairment: | |||
Specifically evaluated | 1,236 | 1,956 | |
Collectively evaluated | 79,037 | 208,170 | |
Total loans held-for-investment | 80,273 | 210,126 | |
Commercial | Construction | Real estate loans | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | 776 | 590 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | (776) | (97) | |
Ending balance | 0 | 493 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 0 | 0 | |
General portfolio allocation | 0 | 776 | |
Total allowance for loan losses | 0 | 493 | 776 |
Loans evaluated for impairment: | |||
Specifically evaluated | 0 | 0 | |
Collectively evaluated | 0 | 7,502 | |
Total loans held-for-investment | 0 | 7,502 | |
Commercial and Industrial | Commercial and industrial | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | 1,566 | 1,931 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | 933 | (1,571) | |
Ending balance | 2,499 | 360 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 0 | 0 | |
General portfolio allocation | 2,499 | 1,566 | |
Total allowance for loan losses | 2,499 | 360 | 1,566 |
Loans evaluated for impairment: | |||
Specifically evaluated | 0 | 0 | |
Collectively evaluated | 432,533 | 335,362 | |
Total loans held-for-investment | 432,533 | 335,362 | |
Reverse Mortgage and Other | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning balance | 12 | 39 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Provision for loan losses | (1) | (21) | |
Ending balance | 11 | 18 | |
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract] | |||
Specifically evaluated impaired loans | 0 | 0 | |
General portfolio allocation | 11 | 12 | |
Total allowance for loan losses | 11 | $ 18 | 12 |
Loans evaluated for impairment: | |||
Specifically evaluated | 646 | 923 | |
Collectively evaluated | 501 | 499 | |
Total loans held-for-investment | $ 1,147 | $ 1,422 |
Loans - Impaired Loans (Details
Loans - Impaired Loans (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Financing Receivable, Impaired [Line Items] | |||
Impaired loans with no related allowance - Unpaid Principal Balance | $ 5,749 | $ 7,485 | |
Impaired loans with no related allowance - Recorded Investment | 5,709 | 6,806 | |
Impaired loans with related allowance - Unpaid Principal Balance | 296 | 323 | |
Impaired loans with related allowance - Recorded Investment | 299 | 302 | |
Impaired loans - Unpaid Principal Balance | 6,045 | 7,808 | |
Impaired loans - Recorded Investment | 6,008 | 7,108 | |
Impaired loans - Related Allowance | 28 | 29 | |
Impaired loans with no related allowance - Average Recorded Investment | 7,211 | $ 15,639 | |
Impaired loans with no related allowance - Interest Income Recognized | 37 | 210 | |
Impaired loans with related allowance - Average Recorded Investment | 300 | 322 | |
Impaired loans with related allowance - Interest Income Recognized | 1 | 1 | |
Impaired loans - Average Recorded Investment | 7,511 | 15,961 | |
Impaired loans - Interest Income Recognized | 38 | 211 | |
Reverse mortgage and other | |||
Financing Receivable, Impaired [Line Items] | |||
Impaired loans with no related allowance - Unpaid Principal Balance | 646 | 914 | |
Impaired loans with no related allowance - Recorded Investment | 646 | 923 | |
Impaired loans with no related allowance - Average Recorded Investment | 829 | 616 | |
Impaired loans with no related allowance - Interest Income Recognized | 0 | 0 | |
Impaired loans with related allowance - Average Recorded Investment | 0 | 258 | |
Impaired loans with related allowance - Interest Income Recognized | 0 | 0 | |
Real estate loans | Residential | One-to-four family | |||
Financing Receivable, Impaired [Line Items] | |||
Impaired loans with no related allowance - Unpaid Principal Balance | 3,866 | 4,616 | |
Impaired loans with no related allowance - Recorded Investment | 3,827 | 3,927 | |
Impaired loans with related allowance - Unpaid Principal Balance | 296 | 323 | |
Impaired loans with related allowance - Recorded Investment | 299 | 302 | |
Impaired loans - Related Allowance | 28 | 29 | |
Impaired loans with no related allowance - Average Recorded Investment | 3,856 | 4,979 | |
Impaired loans with no related allowance - Interest Income Recognized | 17 | 77 | |
Impaired loans with related allowance - Average Recorded Investment | 300 | 64 | |
Impaired loans with related allowance - Interest Income Recognized | 1 | 1 | |
Real estate loans | Commercial | |||
Financing Receivable, Impaired [Line Items] | |||
Impaired loans with no related allowance - Unpaid Principal Balance | 1,237 | 1,955 | |
Impaired loans with no related allowance - Recorded Investment | 1,236 | $ 1,956 | |
Impaired loans with no related allowance - Average Recorded Investment | 2,526 | 9,795 | |
Impaired loans with no related allowance - Interest Income Recognized | 20 | 128 | |
Commercial and industrial | Commercial and industrial | |||
Financing Receivable, Impaired [Line Items] | |||
Impaired loans with no related allowance - Average Recorded Investment | 0 | 249 | |
Impaired loans with no related allowance - Interest Income Recognized | $ 0 | $ 5 |
Loans - Aging Analysis (Details
Loans - Aging Analysis (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Financing Receivable, Past Due [Line Items] | ||
Total | $ 743,456 | $ 894,220 |
Nonaccruing | 3,632 | 4,003 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 210 | 1,176 |
60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 189 | 0 |
Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 2,776 | 2,985 |
Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 3,175 | 4,161 |
Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 740,281 | 890,059 |
Residential | Mortgage warehouse | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 125,435 | 177,115 |
Nonaccruing | 0 | 0 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
Residential | Mortgage warehouse | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Residential | Mortgage warehouse | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Residential | Mortgage warehouse | Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Residential | Mortgage warehouse | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Residential | Mortgage warehouse | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 125,435 | 177,115 |
Reverse mortgage and other | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 1,147 | 1,422 |
Nonaccruing | 646 | 923 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
Reverse mortgage and other | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Reverse mortgage and other | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Reverse mortgage and other | Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Reverse mortgage and other | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Reverse mortgage and other | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 1,147 | 1,422 |
Real estate loans | Residential | One-to-four family | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 94,701 | 105,838 |
Nonaccruing | 2,986 | 3,080 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
Real estate loans | Residential | One-to-four family | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 210 | 1,176 |
Real estate loans | Residential | One-to-four family | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 189 | 0 |
Real estate loans | Residential | One-to-four family | Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 2,776 | 2,985 |
Real estate loans | Residential | One-to-four family | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 3,175 | 4,161 |
Real estate loans | Residential | One-to-four family | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 91,526 | 101,677 |
Real estate loans | Residential | Multi-family | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 9,367 | 56,855 |
Nonaccruing | 0 | 0 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
Real estate loans | Residential | Multi-family | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | Multi-family | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | Multi-family | Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | Multi-family | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | Multi-family | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 9,367 | 56,855 |
Real estate loans | Commercial | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 80,273 | 210,126 |
Nonaccruing | 0 | 0 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
Real estate loans | Commercial | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 80,273 | 210,126 |
Real estate loans | Commercial | Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 7,502 |
Nonaccruing | 0 | 0 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
Real estate loans | Commercial | Construction | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Construction | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Construction | Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Construction | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Construction | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 7,502 |
Commercial and industrial | Commercial and industrial | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 432,533 | 335,362 |
Nonaccruing | 0 | 0 |
Loans Receivable > 89 Days and Accruing | 0 | 0 |
Commercial and industrial | Commercial and industrial | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Commercial and industrial | Commercial and industrial | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Commercial and industrial | Commercial and industrial | Greater than 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Commercial and industrial | Commercial and industrial | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total | 0 | 0 |
Commercial and industrial | Commercial and industrial | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total | $ 432,533 | $ 335,362 |
Loans - Credit Quality Indicato
Loans - Credit Quality Indicators (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | $ 743,456 | $ 894,220 |
Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 724,307 | 879,238 |
Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 14,281 | 10,979 |
Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 4,868 | 4,003 |
Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Residential | Mortgage warehouse | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 125,435 | 177,115 |
Residential | Mortgage warehouse | Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 125,435 | 177,115 |
Residential | Mortgage warehouse | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Residential | Mortgage warehouse | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Residential | Mortgage warehouse | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Reverse mortgage and other | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 1,147 | 1,422 |
Reverse mortgage and other | Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 501 | 499 |
Reverse mortgage and other | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Reverse mortgage and other | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 646 | 923 |
Reverse mortgage and other | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | One-to-four family | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 94,701 | 105,838 |
Real estate loans | Residential | One-to-four family | Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 91,166 | 102,307 |
Real estate loans | Residential | One-to-four family | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 549 | 451 |
Real estate loans | Residential | One-to-four family | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 2,986 | 3,080 |
Real estate loans | Residential | One-to-four family | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | Multi-family | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 9,367 | 56,855 |
Real estate loans | Residential | Multi-family | Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 9,367 | 56,855 |
Real estate loans | Residential | Multi-family | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | Multi-family | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Residential | Multi-family | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 80,273 | 210,126 |
Real estate loans | Commercial | Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 65,305 | 199,598 |
Real estate loans | Commercial | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 13,732 | 10,528 |
Real estate loans | Commercial | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 1,236 | 0 |
Real estate loans | Commercial | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 7,502 |
Real estate loans | Commercial | Construction | Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 7,502 |
Real estate loans | Commercial | Construction | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Construction | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Real estate loans | Commercial | Construction | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Commercial and industrial | Commercial and industrial | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 432,533 | 335,362 |
Commercial and industrial | Commercial and industrial | Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 432,533 | 335,362 |
Commercial and industrial | Commercial and industrial | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Commercial and industrial | Commercial and industrial | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | 0 | 0 |
Commercial and industrial | Commercial and industrial | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Total | $ 0 | $ 0 |
Loans - Held-for-Investment Pur
Loans - Held-for-Investment Purchased and/or Sold (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Purchases | $ 0 | $ 0 |
Sales | 216,061 | 0 |
Loan sales, purchase participating interest | 67,600 | |
Real estate loans | Residential | Multi- Family | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Purchases | 0 | 0 |
Sales | 54,227 | 0 |
Real estate loans | Commercial | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Purchases | 0 | 0 |
Sales | 155,011 | 0 |
Real estate loans | Commercial | Construction | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Purchases | 0 | 0 |
Sales | $ 6,823 | $ 0 |
FHLB Advances and Other Borro_3
FHLB Advances and Other Borrowings - FHLB Advances (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Disclosure [Abstract] | ||
Amount outstanding at period-end | $ 800,000 | $ 0 |
Weighted average interest rate at period-end | 0.43% | 0.00% |
FHLB Advances and Other Borro_4
FHLB Advances and Other Borrowings - Narrative (Details) | Mar. 31, 2022USD ($)bank | Dec. 31, 2021USD ($) |
Short-term Debt [Line Items] | ||
FHLB advances, maximum borrowing capacity in proportion to assets (as a percent) | 35.00% | 35.00% |
FHLB advances, collateral pledged | $ 2,400,000,000 | $ 1,400,000,000 |
FHLB advances, unused borrowing capacity | 1,200,000,000 | 1,000,000,000 |
Federal funds purchased, maximum borrowing capacity | $ 108,000,000 | |
Number of correspondent banks | bank | 2 | |
Federal funds purchased, amount outstanding | $ 0 | 0 |
Federal Reserve Bank Advances | ||
Short-term Debt [Line Items] | ||
FRB advances, collateral pledged | 5,200,000 | 6,000,000 |
FRB advances, current borrowing capacity | 2,900,000 | 5,200,000 |
FRB advances, amount outstanding | $ 0 | $ 0 |
Intangible Assets - Narrative (
Intangible Assets - Narrative (Details) - Libra Association, Diem Networks US HoldCo, Inc., Diem Networks US, Inc., Diem Networks II LLC, Diem LLC, And Diem Networks LLC | Jan. 31, 2022USD ($)shares |
Asset Acquisition [Line Items] | |
Asset acquisition, cash paid | $ 50,000,000 |
Asset acquisition, capitalized direct transaction costs | 8,400,000 |
Asset acquisition, intangible assets | $ 190,000,000 |
Class A Common Stock | |
Asset Acquisition [Line Items] | |
Asset acquisition, number of shares issued (shares) | shares | 1,221,217 |
Asset acquisition, total transaction consideration | $ 181,600,000 |
Subordinated Debentures, Net -
Subordinated Debentures, Net - Narrative (Details) - Subordinated Debentures - USD ($) | Jul. 31, 2021 | Jan. 31, 2005 | Mar. 31, 2022 | Dec. 31, 2021 | Jul. 31, 2001 |
Debt Instrument [Line Items] | |||||
Interest payments, deferment period | 5 years | ||||
Outstanding principal balance | $ 15,800,000 | $ 15,800,000 | |||
Unamortized debt issuance costs | $ 100,000 | $ 100,000 | |||
Trust One | |||||
Debt Instrument [Line Items] | |||||
Minority interest (as a percent) | 3.00% | ||||
Trust Two | |||||
Debt Instrument [Line Items] | |||||
Minority interest (as a percent) | 3.00% | ||||
2001 Subordinated Debentures Maturing July 25, 2031 | Trust One | |||||
Debt Instrument [Line Items] | |||||
Principal amount | $ 12,500,000 | ||||
Effective interest rate (as a percent) | 4.19% | ||||
Redemption price (as a percent) | 100.00% | ||||
2001 Subordinated Debentures Maturing July 25, 2031 | Trust One | London Interbank Offered Rate (LIBOR) | |||||
Debt Instrument [Line Items] | |||||
Basis spread on variable rate (as a percent) | 3.75% | ||||
Interest rate (as a percent) | 0.44% | ||||
2005 Subordinated Debentures Maturing March 15, 2035 | Trust Two | |||||
Debt Instrument [Line Items] | |||||
Principal amount | $ 3,000,000 | ||||
Redemption price (as a percent) | 100.00% | ||||
2005 Subordinated Debentures Maturing March 15, 2035 | Trust Two | London Interbank Offered Rate (LIBOR) | |||||
Debt Instrument [Line Items] | |||||
Basis spread on variable rate (as a percent) | 1.85% | ||||
Interest rate (as a percent) | 0.83% | ||||
Effective interest rate (as a percent) | 2.68% |
Derivative and Hedging Activi_3
Derivative and Hedging Activities - Narrative (Details) $ in Millions | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||
Oct. 31, 2021USD ($) | Mar. 31, 2022USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2021USD ($)instrument | Dec. 31, 2012USD ($) | Dec. 31, 2020USD ($)instrument | Dec. 31, 2019USD ($)instrument | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Estimated net derivative gain included in OCI to be reclassified into earnings | $ 1.6 | ||||||
Estimated time for net derivative gain included in OCI to be reclassified into earnings | 12 months | ||||||
Interest Rate Swap | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Number of derivative instruments | instrument | 2 | ||||||
Derivative, notional amount | $ 14.3 | ||||||
Gain on sale of derivatives | $ 0.9 | ||||||
Interest Rate Floor | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Number of derivative instruments | instrument | 20 | ||||||
Derivative, notional amount | $ 400 | ||||||
Gain on sale of derivatives | $ 8.4 | ||||||
Upfront fee paid to counterparty | $ 20.8 | ||||||
Derivative, notional amount sold | 200 | ||||||
Proceeds from sale of derivative | $ 13 | ||||||
Recognition period for net gain on sale of derivative | 4 years 1 month 6 days | ||||||
Interest Rate Cap | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Number of derivative instruments | instrument | 26 | ||||||
Derivative, notional amount | $ 552.8 | ||||||
Gain on sale of derivatives | 0.4 | ||||||
Upfront fee paid to counterparty | $ 24.7 | $ 2.5 | |||||
Derivative, notional amount sold | 16.5 | ||||||
Proceeds from sale of derivative | $ 1.1 | ||||||
Cap Agreement Expiring July 25, 2022 | Interest Rate Cap | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Derivative, notional amount | 12.5 | ||||||
Cap Agreement Expiring March 15, 2022 | Interest Rate Cap | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Derivative, notional amount | $ 3 | ||||||
Fed Funds Rate | Interest Rate Floor | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Floor interest rate (as a percent) | 2.50% | ||||||
Fed Funds Rate | Interest Rate Cap | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Floor interest rate (as a percent) | 2.00% | ||||||
London Interbank Offered Rate (LIBOR) | Interest Rate Floor | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Floor interest rate (as a percent) | 2.25% | ||||||
London Interbank Offered Rate (LIBOR) | Cap Agreement Expiring July 25, 2022 | Interest Rate Cap | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Cap interest rate (as a percent) | 0.75% | ||||||
London Interbank Offered Rate (LIBOR) | Cap Agreement Expiring March 15, 2022 | Interest Rate Cap | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Cap interest rate (as a percent) | 0.50% |
Derivative and Hedging Activi_4
Derivative and Hedging Activities - Fair Value by Balance Sheet Location (Details) - Derivative assets - Derivatives designated as hedging instruments - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Interest Rate Floor | Cash Flow Hedging | ||
Derivatives, Fair Value [Line Items] | ||
Derivative assets | $ 13,671 | $ 18,992 |
Interest Rate Cap | Cash Flow Hedging | ||
Derivatives, Fair Value [Line Items] | ||
Derivative assets | 0 | 0 |
Interest Rate Cap | Fair Value Hedging | ||
Derivatives, Fair Value [Line Items] | ||
Derivative assets | $ 32,744 | $ 15,064 |
Derivative and Hedging Activi_5
Derivative and Hedging Activities - Cumulative Amount of Fair Value Hedging Adjustments (Details) - Securities available-for-sale - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Carrying Amount of the Hedged Asset (Liability) | $ 742,461 | $ 697,437 |
Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedged Assets/(Liabilities) | $ (3,347) | $ 0 |
Derivative and Hedging Activi_6
Derivative and Hedging Activities - Amount of Gain (Loss) Recognized in OCI and Reclassified into Income (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Amount of Gain (Loss) Recognized in OCI | $ 14,603 | $ (7,460) |
Interest income - Other interest earning assets | 1,385 | 1,279 |
Interest income - Taxable securities | 17,779 | 3,592 |
Interest expense - Subordinated debentures | (252) | (245) |
Derivatives designated as hedging instruments | Reclassification out of Accumulated Other Comprehensive Income | Cash Flow Hedging | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Interest income - Other interest earning assets | 131 | 136 |
Interest income - Taxable securities | 1,032 | 1,052 |
Interest expense - Subordinated debentures | (96) | (99) |
Derivatives designated as hedging instruments | Cash flow hedge interest rate floor | Cash Flow Hedging | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Amount of Gain (Loss) Recognized in OCI | (857) | (1,450) |
Derivatives designated as hedging instruments | Cash flow hedge interest rate floor | Cash Flow Hedging | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Amount of Gain (Loss) Recognized in OCI | (3,426) | (5,800) |
Derivatives designated as hedging instruments | Interest Rate Cap | Cash Flow Hedging | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Amount of Gain (Loss) Recognized in OCI | 0 | 0 |
Derivatives designated as hedging instruments | Interest Rate Cap | Fair Value Hedging | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Amount of Gain (Loss) Recognized in OCI | $ 19,448 | $ 375 |
Derivative and Hedging Activi_7
Derivative and Hedging Activities - Effect of Fair Value Hedge Accounting (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Interest income - Taxable securities | $ 17,779 | $ 3,592 |
Interest income - Tax-exempt securities | 13,184 | 1,695 |
Interest Rate Cap | Fair Value Hedging | ||
Interest rate contracts: | ||
Amount excluded from effectiveness testing recognized in earnings based on amortization approach | (610) | (25) |
Interest Rate Cap | Fair Value Hedging | Interest income - Taxable securities | ||
Interest rate contracts: | ||
Hedged items | 0 | (1,072) |
Interest Rate Cap | Fair Value Hedging | Interest income - Tax-exempt securities | ||
Interest rate contracts: | ||
Hedged items | (3,701) | (743) |
Derivatives designated as hedging instruments | Interest Rate Cap | Fair Value Hedging | Interest income - Taxable securities | ||
Interest rate contracts: | ||
Derivatives designated as hedging instruments | 0 | 1,053 |
Derivatives designated as hedging instruments | Interest Rate Cap | Fair Value Hedging | Interest income - Tax-exempt securities | ||
Interest rate contracts: | ||
Derivatives designated as hedging instruments | $ 3,701 | $ 743 |
Income Taxes - Effective Income
Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Amount | ||
Statutory federal tax | $ 7,222 | $ 2,415 |
State tax, net of federal benefit | 2,840 | (451) |
Tax credits | (38) | (41) |
Tax-exempt income, net | (2,994) | (347) |
Excess tax benefit from stock-based compensation | (29) | (3,003) |
Other items, net | 14 | 216 |
Actual tax expense (benefit) | $ 7,015 | $ (1,211) |
Rate | ||
Statutory federal tax | 21.00% | 21.00% |
State tax, net of federal benefit | 8.30% | (3.90%) |
Tax credits | (0.10%) | (0.40%) |
Tax-exempt income, net | (8.70%) | (3.00%) |
Excess tax benefit from stock-based compensation | (0.10%) | (26.10%) |
Other items, net | 0.00% | 1.90% |
Actual tax expense (benefit) | 20.40% | (10.50%) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Income tax expense (benefit) | $ 7,015 | $ (1,211) | |
Effective tax rate (as a percent) | 20.40% | (10.50%) | |
Deferred tax asset | $ 97,100 | $ 6,500 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions | Mar. 31, 2022 | Dec. 31, 2021 |
Commitments and Contingencies Disclosure [Abstract] | ||
Allowance for commitments | $ 1.6 | $ 0.6 |
Commitments and Contingencies_2
Commitments and Contingencies - Off-Balance Sheet Items (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Instrument [Line Items] | ||
Total credit extension commitments | $ 644,430 | $ 248,576 |
Unfunded lines of credit | ||
Debt Instrument [Line Items] | ||
Total credit extension commitments | 643,609 | 248,092 |
Letters of credit | ||
Debt Instrument [Line Items] | ||
Total credit extension commitments | $ 821 | $ 484 |
Stock-based Compensation - Narr
Stock-based Compensation - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Jun. 30, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation expense | $ 0.7 | $ 0.3 | |
Stock options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Unrecognized stock-based compensation expense related to stock options | $ 2.2 | ||
Period unrecognized expenses is expected to be recognized | 2 years 4 months 24 days | ||
Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Period unrecognized expenses is expected to be recognized | 2 years 7 months 6 days | ||
Unrecognized stock-based compensation expense | $ 6.1 | ||
2018 Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares authorized (shares) | 1,596,753 |
Stock-based Compensation - Stoc
Stock-based Compensation - Stock Compensation Plans (Details) $ / shares in Units, $ in Thousands | 3 Months Ended |
Mar. 31, 2022USD ($)$ / sharesshares | |
Number of Options | |
Outstanding at beginning of period (shares) | shares | 191,191 |
Granted (shares) | shares | 29,117 |
Exercised (shares) | shares | (1,840) |
Forfeited or expired (shares) | shares | (1,511) |
Outstanding at end of period (shares) | shares | 216,957 |
Exercisable at end of period (shares) | shares | 99,654 |
Vested or Expected to Vest at end of period (shares) | shares | 209,715 |
Weighted Average Exercise Price | |
Outstanding at beginning of period (USD per share) | $ / shares | $ 24.97 |
Granted (USD per share) | $ / shares | 110.84 |
Exercised (USD per share) | $ / shares | 16.09 |
Forfeited or expired (USD per share) | $ / shares | 16.09 |
Outstanding at end of period (USD per share) | $ / shares | 36.63 |
Exercisable at end of period (USD per share) | $ / shares | 19.28 |
Vested or Expected to Vest at end of period (USD per share) | $ / shares | $ 36.34 |
Weighted Average Remaining Contractual Life (in years) | |
Outstanding at end of period | 7 years 3 months 18 days |
Exercisable at end of period | 6 years |
Vested or Expected to Vest at end of period | 7 years 2 months 12 days |
Aggregate Intrinsic Value (in thousands) | |
Outstanding at end of period | $ | $ 24,720 |
Exercisable at end of period | $ | 13,083 |
Vested or Expected to Vest at end of period | $ | $ 23,956 |
Stock-based Compensation - Rest
Stock-based Compensation - Restricted Stock Units Activity (Details) - Restricted Stock Units | 3 Months Ended |
Mar. 31, 2022$ / sharesshares | |
Number of Shares | |
Beginning balance (shares) | shares | 56,871 |
Granted (shares) | shares | 43,165 |
Vested (shares) | shares | (7,128) |
Forfeited (shares) | shares | (1,029) |
Ending balance (shares) | shares | 91,879 |
Weighted-Average Grant Date Fair Value Per Share | |
Beginning balance (USD per share) | $ / shares | $ 72.53 |
Granted (USD per share) | $ / shares | 110.84 |
Vested (USD per share) | $ / shares | 122.91 |
Forfeited (USD per share) | $ / shares | 71.99 |
Ending balance (USD per share) | $ / shares | $ 86.63 |
Regulatory Capital - Summary (D
Regulatory Capital - Summary (Details) $ in Thousands | Mar. 31, 2022USD ($) | Dec. 31, 2021USD ($) |
The Company | ||
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items] | ||
Tier 1 leverage ratio, amount | $ 1,597,946 | $ 1,631,257 |
Tier 1 leverage ratio (as a percent) | 0.0968 | 0.1107 |
Tier 1 leverage ratio, minimum capital adequacy, amount | $ 660,633 | $ 589,614 |
Tier 1 leverage ratio, minimum capital adequacy (as a percent) | 0.0400 | 0.0400 |
Common equity tier 1 capital ratio, amount | $ 1,388,825 | $ 1,422,136 |
Common equity tier 1 capital ratio (as a percent) | 0.3897 | 0.4953 |
Common equity tier 1 capital ratio, minimum capital adequacy, amount | $ 160,360 | $ 129,198 |
Common equity tier 1 capital ratio, minimum capital adequacy (as a percent) | 0.0450 | 0.0450 |
Tier 1 risk-based capital ratio, amount | $ 1,597,946 | $ 1,631,257 |
Tier 1 risk-based capital ratio (as a percent) | 0.4484 | 0.5682 |
Tier 1 risk-based capital ratio, minimum capital adequacy, amount | $ 213,813 | $ 172,264 |
Tier 1 risk-based capital ratio, minimum capital adequacy (as a percent) | 0.0600 | 0.0600 |
Total risk-based capital ratio, amount | $ 1,603,983 | $ 1,638,794 |
Total risk-based capital ratio (as a percent) | 0.4501 | 0.5708 |
Total risk-based capital ratio, minimum capital adequacy, amount | $ 285,084 | $ 229,686 |
Total risk-based capital ratio, minimum capital adequacy (as a percent) | 0.0800 | 0.0800 |
The Bank | ||
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items] | ||
Tier 1 leverage ratio, amount | $ 1,577,199 | $ 1,546,693 |
Tier 1 leverage ratio (as a percent) | 0.0951 | 0.1049 |
Tier 1 leverage ratio, minimum capital adequacy, amount | $ 663,196 | $ 589,595 |
Tier 1 leverage ratio, minimum capital adequacy (as a percent) | 0.0400 | 0.0400 |
Tier 1 leverage ratio, to be well capitalized, amount | $ 828,995 | $ 736,994 |
Tier 1 leverage ratio, to be well capitalized (as a percent) | 0.0500 | 0.0500 |
Common equity tier 1 capital ratio, amount | $ 1,577,199 | $ 1,546,693 |
Common equity tier 1 capital ratio (as a percent) | 0.4428 | 0.5389 |
Common equity tier 1 capital ratio, minimum capital adequacy, amount | $ 160,273 | $ 129,162 |
Common equity tier 1 capital ratio, minimum capital adequacy (as a percent) | 0.0450 | 0.0450 |
Common equity tier 1 capital ratio, to be well capitalized, amount | $ 231,505 | $ 186,567 |
Common equity tier 1 capital ratio, to be well capitalized (as a percent) | 6.50% | 6.50% |
Tier 1 risk-based capital ratio, amount | $ 1,577,199 | $ 1,546,693 |
Tier 1 risk-based capital ratio (as a percent) | 0.4428 | 0.5389 |
Tier 1 risk-based capital ratio, minimum capital adequacy, amount | $ 213,697 | $ 172,216 |
Tier 1 risk-based capital ratio, minimum capital adequacy (as a percent) | 0.0600 | 0.0600 |
Tier 1 risk-based capital ratio, to be well capitalized, amount | $ 284,929 | $ 229,622 |
Tier 1 risk-based capital ratio, to be well capitalized (as a percent) | 0.0800 | 0.0800 |
Total risk-based capital ratio, amount | $ 1,583,236 | $ 1,554,230 |
Total risk-based capital ratio (as a percent) | 0.4445 | 0.5415 |
Total risk-based capital ratio, minimum capital adequacy, amount | $ 284,929 | $ 229,622 |
Total risk-based capital ratio, minimum capital adequacy (as a percent) | 0.0800 | 0.0800 |
Total risk-based capital ratio, to be well capitalized, amount | $ 356,161 | $ 287,027 |
Total risk-based capital ratio, to be well capitalized (as a percent) | 0.1000 | 0.1000 |
Fair Value - Recurring Basis (D
Fair Value - Recurring Basis (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Assets | ||
Securities available-for-sale | $ 9,463,494 | $ 8,625,259 |
Derivative assets | 46,415 | 34,056 |
Recurring Basis | ||
Assets | ||
Securities available-for-sale | 9,463,494 | 8,625,259 |
Derivative assets | 46,415 | 34,056 |
Total | 9,509,909 | 8,659,315 |
Recurring Basis | Level 1 | ||
Assets | ||
Securities available-for-sale | 176,343 | 0 |
Derivative assets | 0 | 0 |
Total | 176,343 | 0 |
Recurring Basis | Level 2 | ||
Assets | ||
Securities available-for-sale | 9,287,151 | 8,625,259 |
Derivative assets | 46,415 | 34,056 |
Total | 9,333,566 | 8,659,315 |
Recurring Basis | Level 3 | ||
Assets | ||
Securities available-for-sale | 0 | 0 |
Derivative assets | 0 | 0 |
Total | $ 0 | $ 0 |
Fair Value - Narrative (Details
Fair Value - Narrative (Details) - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
Assets | ||
Assets measured at fair value | $ 742,784,000 | $ 891,166,000 |
Non-recurring basis | ||
Assets | ||
Assets measured at fair value | $ 0 | $ 0 |
Fair Value - Fair Value by Bala
Fair Value - Fair Value by Balance Sheet Grouping (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Financial assets: | ||
Cash and due from banks, Carrying Amount | $ 207,304 | $ 208,193 |
Cash and due from banks, Fair Value | 207,304 | 208,193 |
Interest earning deposits, Carrying Amount | 1,178,205 | 5,179,753 |
Interest earning deposits, Fair Value | 207,304 | 208,193 |
Securities held-to-maturity, Carrying Amount | 2,751,625 | 0 |
Securities held-to-maturity, Fair Value | 2,578,976 | |
Loans held-for-sale, Carrying Amount | 937,140 | 893,194 |
Loans held-for-sale, Fair Value | 937,140 | 893,194 |
Loans held-for-investment, net, Carrying Amount | 739,014 | 887,304 |
Loans held-for-investment, net, Fair Value | 742,784 | 891,166 |
Accrued interest receivable, Carrying Amount | 62,573 | 40,370 |
Accrued interest receivable, Fair Value | 62,573 | 40,370 |
Financial liabilities: | ||
Deposits, Carrying Amount | 13,396,162 | 14,290,628 |
Deposits, Fair Value | 12,839,700 | 14,167,200 |
FHLB advances, Carrying Amount | 800,000 | 0 |
FHLB advances, Fair Value | 800,000 | |
Subordinated debentures, net, Carrying Amount | 15,848 | 15,845 |
Subordinated debentures, net, Fair Value | 15,745 | 15,646 |
Accrued interest payable, Carrying Amount | 111 | 223 |
Accrued interest payable, Fair Value | 111 | 223 |
Interest earning deposits | ||
Financial assets: | ||
Cash and due from banks, Fair Value | 1,178,205 | 5,179,753 |
Interest earning deposits, Fair Value | 1,178,205 | 5,179,753 |
Level 1 | ||
Financial assets: | ||
Cash and due from banks, Fair Value | 207,304 | 208,193 |
Interest earning deposits, Fair Value | 207,304 | 208,193 |
Securities held-to-maturity, Fair Value | 1,202,805 | |
Loans held-for-sale, Fair Value | 0 | 0 |
Loans held-for-investment, net, Fair Value | 0 | 0 |
Accrued interest receivable, Fair Value | 158 | 41 |
Financial liabilities: | ||
Deposits, Fair Value | 0 | 0 |
FHLB advances, Fair Value | 0 | |
Subordinated debentures, net, Fair Value | 0 | 0 |
Accrued interest payable, Fair Value | 0 | 0 |
Level 1 | Interest earning deposits | ||
Financial assets: | ||
Cash and due from banks, Fair Value | 1,178,205 | 5,179,753 |
Interest earning deposits, Fair Value | 1,178,205 | 5,179,753 |
Level 2 | ||
Financial assets: | ||
Cash and due from banks, Fair Value | 0 | 0 |
Interest earning deposits, Fair Value | 0 | 0 |
Securities held-to-maturity, Fair Value | 1,376,171 | |
Loans held-for-sale, Fair Value | 937,140 | 893,194 |
Loans held-for-investment, net, Fair Value | 0 | 0 |
Accrued interest receivable, Fair Value | 17,070 | 8,980 |
Financial liabilities: | ||
Deposits, Fair Value | 12,839,700 | 14,167,200 |
FHLB advances, Fair Value | 800,000 | |
Subordinated debentures, net, Fair Value | 15,745 | 15,646 |
Accrued interest payable, Fair Value | 111 | 223 |
Level 2 | Interest earning deposits | ||
Financial assets: | ||
Cash and due from banks, Fair Value | 0 | 0 |
Interest earning deposits, Fair Value | 0 | 0 |
Level 3 | ||
Financial assets: | ||
Cash and due from banks, Fair Value | 0 | 0 |
Interest earning deposits, Fair Value | 0 | 0 |
Securities held-to-maturity, Fair Value | 0 | |
Loans held-for-sale, Fair Value | 0 | 0 |
Loans held-for-investment, net, Fair Value | 742,784 | 891,166 |
Accrued interest receivable, Fair Value | 45,345 | 31,349 |
Financial liabilities: | ||
Deposits, Fair Value | 0 | 0 |
FHLB advances, Fair Value | 0 | |
Subordinated debentures, net, Fair Value | 0 | 0 |
Accrued interest payable, Fair Value | 0 | 0 |
Level 3 | Interest earning deposits | ||
Financial assets: | ||
Cash and due from banks, Fair Value | 0 | 0 |
Interest earning deposits, Fair Value | $ 0 | $ 0 |
Earnings Per Share - Summary (D
Earnings Per Share - Summary (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Basic | ||
Net income | $ 27,386 | $ 12,710 |
Less: Dividends paid to preferred shareholders | 2,688 | 0 |
Net income available to common shareholders. basic | $ 24,698 | $ 12,710 |
Weighted average common shares outstanding (shares) | 31,219 | 22,504 |
Basic earnings per common share (USD per share) | $ 0.79 | $ 0.56 |
Diluted | ||
Net income available to common shareholders | $ 24,698 | $ 12,710 |
Weighted average common shares outstanding for basic earnings per common share (shares) | 31,219 | 22,504 |
Add: Dilutive effects of stock-based awards (shares) | 182 | 506 |
Average shares and dilutive potential common shares (shares) | 31,401 | 23,010 |
Dilutive earnings per common share (USD per share) | $ 0.79 | $ 0.55 |
Earnings Per Share - Narrative
Earnings Per Share - Narrative (Details) - shares shares in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Earnings Per Share [Abstract] | ||
Stock awards excluded from computation of diluted earnings per share (shares) | 48 | 44 |
Shareholders' Equity - Narrativ
Shareholders' Equity - Narrative (Details) - USD ($) | Jan. 31, 2022 | Jan. 14, 2022 | Dec. 09, 2021 | Oct. 14, 2021 | Aug. 04, 2021 | Mar. 09, 2021 | Jan. 26, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | Jun. 30, 2021 | Dec. 31, 2021 |
Class of Stock [Line Items] | |||||||||||
Preferred stock authorized (shares) | 10,000,000 | 10,000,000 | |||||||||
Preferred stock, par value (USD per share) | $ 0.01 | $ 0.01 | |||||||||
Liquidation preference (USD per share) | $ 1,000 | $ 1,000 | |||||||||
Aggregate gross proceeds of stock offering | $ 131,517,000 | $ 423,540,000 | |||||||||
Preferred stock, dividend declared (USD per share) | $ 13.44 | $ 15.08 | |||||||||
Preferred stock, total dividend | $ 2,700,000 | $ 3,000,000 | 2,688,000 | ||||||||
Proceeds from common stock issuance, net | $ (57,000) | $ 423,540,000 | |||||||||
Class A Common Stock | |||||||||||
Class of Stock [Line Items] | |||||||||||
Common stock authorized (shares) | 125,000,000 | 125,000,000 | |||||||||
Common stock, par value (USD per share) | $ 0.01 | $ 0.01 | |||||||||
Class A Common Stock | Libra Association, Diem Networks US HoldCo, Inc., Diem Networks US, Inc., Diem Networks II LLC, Diem LLC, And Diem Networks LLC | |||||||||||
Class of Stock [Line Items] | |||||||||||
Asset acquisition, number of shares issued (shares) | 1,221,217 | ||||||||||
Asset acquisition, price per share (USD per share) | $ 107.74 | ||||||||||
Asset acquisition, total value | $ 131,600,000 | ||||||||||
Class A Common Stock | Follow-on Offering, including Over-Allotment Option | |||||||||||
Class of Stock [Line Items] | |||||||||||
Stock sold during period (shares) | 3,806,895 | 4,563,493 | |||||||||
Aggregate gross proceeds of stock offering | $ 287,500,000 | ||||||||||
Offering price per share (USD per share) | $ 145 | $ 63 | |||||||||
Proceeds from common stock issuance, net | $ 530,300,000 | $ 272,400,000 | |||||||||
Aggregate gross proceeds of stock offering | $ 552,000,000 | ||||||||||
Class A Common Stock | Over-Allotment Option | |||||||||||
Class of Stock [Line Items] | |||||||||||
Stock sold during period (shares) | 496,551 | 595,238 | |||||||||
Class A Common Stock | ATM Program | |||||||||||
Class of Stock [Line Items] | |||||||||||
Stock sold during period (shares) | 2,793,826 | ||||||||||
Offering price per share (USD per share) | $ 107.38 | ||||||||||
Proceeds from common stock issuance, net | $ 295,100,000 | ||||||||||
Aggregate gross sales price | $ 300,000,000 | ||||||||||
Class B Common Stock | |||||||||||
Class of Stock [Line Items] | |||||||||||
Common stock authorized (shares) | 25,000,000 | 25,000,000 | |||||||||
Common stock, par value (USD per share) | $ 0.01 | $ 0.01 | |||||||||
Series A Non-Cumulative Perpetual Preferred Stock, Depositary Share | |||||||||||
Class of Stock [Line Items] | |||||||||||
Stock sold during period (shares) | 8,000,000 | ||||||||||
Liquidation preference (USD per share) | $ 25 | ||||||||||
Aggregate gross proceeds of stock offering | $ 200,000,000 | ||||||||||
Proceeds from preferred stock issuance, net | $ 193,600,000 | ||||||||||
Preferred stock, dividend declared (USD per share) | $ 0.336 | $ 0.377 | |||||||||
Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A | |||||||||||
Class of Stock [Line Items] | |||||||||||
Preferred stock, par value (USD per share) | $ 0.01 | ||||||||||
Ownership interest per depositary share | 2.50% | ||||||||||
Preferred stock, fixed rate | 5.375% | ||||||||||
Liquidation preference (USD per share) | $ 1,000 |
Subsequent Event - Narrative (D
Subsequent Event - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | Apr. 11, 2022 | Jan. 14, 2022 | Oct. 14, 2021 | Mar. 31, 2022 |
Subsequent Event [Line Items] | ||||
Preferred stock, dividend declared (USD per share) | $ 13.44 | $ 15.08 | ||
Preferred stock, total dividend | $ 2,700 | $ 3,000 | $ 2,688 | |
Series A Non-Cumulative Perpetual Preferred Stock, Depositary Share | ||||
Subsequent Event [Line Items] | ||||
Preferred stock, dividend declared (USD per share) | $ 0.336 | $ 0.377 | ||
Subsequent Event | ||||
Subsequent Event [Line Items] | ||||
Preferred stock, dividend declared (USD per share) | $ 13.44 | |||
Preferred stock, total dividend | $ 2,700 | |||
Subsequent Event | Series A Non-Cumulative Perpetual Preferred Stock, Depositary Share | ||||
Subsequent Event [Line Items] | ||||
Preferred stock, dividend declared (USD per share) | $ 0.336 |